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Sickle cell disease (SCD), a common genetic blood disorder affecting primarily 
African-Americans (Edwards, Scales, Loughlin, Bennett, Harris-Peterson, et al., 2005) 
causes a vaso-occlusive pain episode (VOPE) affecting both men and women across 
their life span. Both physical and psychological stress has been reported to precipitate a 
VOPE (Anie & Green, 2006) placing them at risk for early death. In fact, 78% of the 
patients who die from SCD do so during a VOPE. 
 Healing Touch (HT), a complementary therapy, has been shown to decrease 
anxiety, stress, and pain in other patient populations such as cancer, orthopedic, and 
post-cardiac surgery patients, but sickle cell pain has not been studied. The purpose of 
this parallel-group randomized control trial (RCT) was to determine the effectiveness of 
Healing Touch on anxiety, stress, pain, pain medication usage, and selected 
physiological measures of hospitalized SCD adults experiencing a VOPE. The outcome 
variables were measured, while controlling for the music and presence. The study 
 sample was 24 participants who ranged in age from 22 to 49 years with an average age 
of 31.4 years. Healing Touch sessions were administered for 30 minutes on four 
consecutive days, and the self-reported data on anxiety, stress, pain, and the selected 
physiological data were collected. 
 The results on the 16 patients who completed the study were not statistically 
significant across the two groups due to the small sample size. Overall, there were no 
statistically significant changes in any between group comparisons, except for present 
pain on day 4 for the Attention Control with Music (ACM) group. For both Healing Touch 
with Music (HTM) and the ACM, the within groups comparison showed a reduction in 
physiological parameters, but was not statistically significant. For anxiety, the within 
groups comparison showed a statistically significant reduction for the ACM group 
(p=.01). For stress, the ACM group reached a statistically significant reduction (p=.03), 
after day 4, however the HTM group also reached statistical significance after day 2 
(p=.02) and again after day 4 (p=01), consistent with the findings from previous studies 
in HT. 
The pre- to post-intervention reductions in present pain were greater in the HTM 
group than the ACM group across all 4 days. The only statistically significant within 
groups findings for present pain reduction were in the HTM group (p<.01) on day 1, 
consistent with other studies done with HT. The trends identified in this study warrant 
further research on Healing Touch’s effect on anxiety, stress, and pain using a larger 
sample. 
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CHAPTER 1: INTRODUCTION 
 Sickle cell disease (SCD) affects approximately one out of every 375 African-
Americans in the United States (Edwards et al., 2005). Although SCD has been found to 
primarily affect people of African-American and Caribbean descent, it has also been 
found in a small portion of the population from Southern Europe, the Mediterranean 
area, the Middle East, and India (NAHAT, 1991). This common genetic blood disorder is 
a worldwide health problem that affects both men and women of all ages during their 
lifetime, with an average lifespan of 42 years for males and 48 for females (Platt et al., 
1994). Seventy-eight percent of the patients who die from SCD will do so during an 
acute vaso-occlusive pain episode (VOPE), such as an episode of acute chest 
syndrome (Platt et al., 1994). Vaso-occlusive pain episodes are due to the insidious 
accumulation of vascular damage caused by the sickling of the red blood cells (Powars, 
Chan, Hiti, Ramicone, & Johnson, 2005). This pain is accompanied by physiological 
changes such as increased heart rate, blood pressure, and respirations, as well as a 
decrease in oxygen saturation and skin temperature (Kleinknecht, 2002).  
 The psychological state of anxiety has been reported as being a contributing 
factor in the frequency and severity of pain in SCD patients, as well as reinforcing the 
pain state (Gil, Abrams, Phillips, & Keefe, 1989; McCrae & Lumley, 1998; Vichinsky, 
Johnson, & Lubin, 1982). Stress has also been identified as one of the precipitating 
factors in the onset of VOPE (Gil et al., 2003; Gil et al., 2004; Leavell & Ford, 1983; 
Porter, Gil, Carson, Anthony, & Ready, 2000; Porter et al., 1998; Thompson, Gil, 
Abrams, & Phillips, 1992). Research directed toward reducing these two precipitating 
factors in SCD needs to be conducted in an effort to improve SCD patients’ outcomes. 
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 Healing Touch (HT), a non-invasive, complementary, energy-based therapy, has 
been shown to decrease anxiety, stress, and pain in cancer, orthopedic, and post-
cardiac surgery patients, but no studies have been conducted in the area of sickle cell 
pain. The purpose of this pilot study was to examine the effectiveness of a non-invasive 
nursing intervention, HT, on anxiety, stress, pain, equianalgesic opioid medication 
usage, and physiological measures (i.e. blood pressure, heart rate, respirations, oxygen 
saturation, and skin temperature) of hospitalized SCD adults experiencing a VOPE. The 
effect of HT on the outcome variables was measured by 1) selected physiological 
parameters, 2) self-reported levels of anxiety, stress, and pain, as well as 3) 
equianalgesic opioid medication received during the study period, while controlling for 
the variables music and presence.  
The Purpose of the Study - Problem 
 Among the various complications of sickle cell disease, the numerous severe 
pain episodes present a challenge for the care given by the bedside nurse. Pain 
episodes can be acute or chronic, and have unpredictable frequency, severity, and 
location (National Heart, Lung, and Blood Institute, 2002). Sixty percent of patients with 
SCD will have three to ten episodes of severe pain every year (Platt et al., 1991). Acute 
VOPE have been found to be the cause of pain in most patients and will resolve in 
about five to seven days, but can last for several weeks to months (Yale, Nagib, & 
Guthrie, 2000).  
 Physical and psychological stress has been reported to precipitate a VOPE (Anie 
& Green, 2006). Examining anxiety and pain coping strategies in SCD patients, a 
significant correlation has been found between anxiety and the number of pain 
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episodes, duration, and severity of the pain (Gil, et al., 2003; Leavell & Ford, 1983). 
Higher levels of stress have also been shown to predict pain severity (Gil, et al., 2003). 
Anxiety and stress activate the neural impulses that stimulate the sympathetic nervous 
system to release the hormones epinephrine and norepinephrine, which causes an 
increase in heart rate (HR), blood pressure (BP), respiratory rate (RR), and oxygen 
consumption as well as dilating the bronchi and decreasing blood flow to the periphery 
(Kleinknecht, 2002). The effect of emotion-induced sympathetic activation related to 
stressful life experiences in the activation of the body’s sympathetic responses (i.e. 
respiratory and blood flow patterns) needs to be examined, therefore the physiological 
measures that reflect a relaxation response (i.e. a decrease in HR, BP, and RR) were 
collected in this study to determine what role sympathetic arousal plays in the 
precipitation, exacerbation, and prolonging of VOPE (McCrae & Lumley, 1998). 
 Sickle cell disease patients, a health disparity population, are vulnerable to the 
biases of many healthcare providers who fear the SCD patient’s potential for addiction 
to narcotics used to control pain (Elander & Midence, 1996; Shapiro & Ballas, 1994), yet 
inadequate pain management by the healthcare provider can cause stress induced 
VOPE and repeated hospital admissions (Ballas & Lusardi, 2005). Increased VOPE 
have been found to have a negative impact on the patients’ quality of life and to 
increase their overall morbidity and mortality (Ballas & Lusardi, 2005). 
  The pathophysiology of SCD, the psychological and social factors, can 
contribute to the SCD patient’s complaints of pain (Anie, Steptoe, Ball, Dick, & Smalling, 
2002; Edwards, Telfair, Cecil & Lenoci, 2001). Current management of SCD is directed 
toward relieving the symptoms and complications, because the more disease symptoms 
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experienced during a VOPE by the SCD patient, the higher the risk for an early death 
(Edwards et al., 2005; Platt et al., 1994). Maville, Bowen, and Benham (2008) reported 
measuring selected physiological parameters after providing a HT session for healthy 
adults and found changes in their HR and peripheral temperature, which suggested a 
reduction in sympathetic tone with resultant relaxation occurring. This was consistent 
with findings from five other studies, which reported selected physiological data related 
to anxiety and/or stress (Heidt, 1981; Meehan, 1993; Wardell & Engebretson, 2001; 
Wardell & Weymouth, 2004; Wilkinson et al., 2002). This study was directed toward 
using a noninvasive nursing intervention, HT, to determine if it can be effective in 
lessening or delaying some of the symptoms and complications (i.e. anxiety, stress, and 
pain) associated with SCD. 
 The majority of the interventional research for SCD management use invasive 
techniques such as blood transfusions, IV hydroxyurea, and bone marrow 
transplantation, which carry much higher complication rates (Dunlop & Bennett, 2007; 
Steinberg & Brugnara, 2003). Cognitive-behavioral techniques have been the primary 
focus of non-pharmacological research for SCD patients and often include primary 
coping strategies, hypnosis, thermal biofeedback, and acupuncture (Elander & Midence, 
1996). There is limited data to support the use of these complementary therapies and 
their effectiveness on pain management in the SCD patient. There have been, however, 
a few clinical trials that have shown some positive results with these non-
pharmacological approaches. For example, subjects who learned self-hypnosis or 
biofeedback techniques reported decreased hospitalization and medication usage; 
others, who used biofeedback and self-hypnosis, along with progressive relaxation and 
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cognitive strategies, showed a significant reduction in anxiety and intensity of pain 
(Elander & Midence, 1996).  
 No non-pharmacological studies were found using HT as an intervention for 
reducing anxiety, stress, or pain in the hospitalized SCD adults experiencing a VOPE. If 
HT could be shown to be effective, then it could be administered by the bedside nurse 
as a complementary therapy to reduce pain medications, and it could impact the 
amount of pharmacological interventions needed as well as reduce the number of side 
effects, complications, and costs associated with these medications. Also, with the 
reduction in symptoms and complications, the risk of an early death for the SCD patient 
could potentially be decreased. Therefore, the purpose of this pilot study was to 
examine the effectiveness of a non-invasive nursing intervention, HT, on anxiety, stress, 
pain, equianalgesic opioid medication, and physiological measures (i.e. blood pressure, 
heart rate, respirations, oxygen saturation, and skin temperature) of hospitalized SCD 
adults experiencing a VOPE.  
The Intervention Group – Healing Touch with Background Music (HTM) 
 Healing Touch (HT), developed by Janet Mentgen, BSN, RN in 1980, has been 
classified as a biofield therapy by the National Center for Complementary and 
Alternative Medicine (NCCAM, 2008). Mentgen, building on Martha Rogers (1979) 
description of the energy system that surrounds the body as rhythmical vibrations 
oscillating between man and the environment, developed Healing Touch, an energy-
based therapy, based on the premise that the human body has an energy field that is 
not only part of the physical body, but also extends out several feet from the body. 
Leddy (2004) using Rogers’ Science of Unitary Human Beings, created a model to 
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explain these pattern manifestations within the energy field. The North American Nurses 
Diagnosis Association (NANDA) has established the nursing diagnosis of Energy Field 
Disturbance that describes “a condition in which a disturbance of the human energy 
field manifests a disharmony in the human-environmental energy field’s mutual process” 
(Carpenito-Moyet, 2004, p.344). Leddy’s Human Energy Model (HEM) describes how 
this field can be modified whenever a person experiences anxiety and pain, through 
energetic patterning (participation) using nursing interventions, such as HT, which was 
examined in this study using Betty Neuman’s Health Care System’s Model. Based on 
Neuman’s concept of the patient as “wholes whose parts are in dynamic interaction” in 
an open system “where its elements are continuously exchanging information and 
energy” (Toomey & Alligood, 2006, p 320), this study examined the effects of 
administering HT to the SCD patient experiencing a VOPE to determine if interacting 
with their energy field would  strengthen their lines of resistance and lines of defense 
against the stressors, anxiety and stress, and thereby reduce their pain.   
 Healing Touch, using therapeutic presence (a way of being with another person), 
provides the intentional exchange of energy that can foster harmonious synchronization 
of these energy field vibrations and increase their coherence (Oschman, 2000). This 
coherence will help to strengthen the lines of resistance and lines of defense described 
in Betty Neuman’s Health Care System Model, as an open system in which there is a 
continuous and dynamic interaction between the patient and the environment (Neuman 
& Fawcett, 2002).  
 Measurement of this energy field is difficult however, and until science can 
directly and accurately measure the human energy field, research will continue 
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measuring the indirect effects of various interventions on the field (Eschiti, 2007). This 
present study did just that by examining the effectiveness of the non-invasive nursing 
intervention, HT (on the sickle cell patient’s lines of resistance and defense within 
his/her internal and external environments) on anxiety, stress, pain, equianalgesic 
opioid medication and physiological measures (i.e. blood pressure, heart rate, 
respirations, oxygen saturation, and skin temperature) of hospitalized SCD adults 
experiencing a VOPE.   
Healing Touch incorporates a group of non-invasive techniques using the hands 
to help balance these dynamic energy systems surrounding the body, energizing and 
balancing both the human and environmental fields. By balancing these energy fields, it 
is thought that the practitioner can assist patients in their healing process (Hoover-
Kramer, 2002). Healing Touch, a technique designed to work along with conventional 
medicine, helps restore harmony (accord, agreement) and balance in both the patient’s 
internal and external energy, allowing for self-healing and promoting wellness within the 
whole system.  
Healing Touch has been shown to reduce such factors as anxiety and stress in 
several different patient populations. A reduction in anxiety along with decreased pain 
was reported in one study with several groups of patients who had multiple diagnoses 
(Welcher & Kish, 2001), as well as another group with end-stage liver disease 
(Hjersted-Smith & Jones, 2006). A more recent study conducted by Maville, Bowen, and 
Benham (2008) investigated the effect of HT on anxiety and physiological measures of 
HR, BP, and skin temperature in healthy adults, and found changes in a number of 
physiological measures which suggested a reduction in anxiety. The literature on stress 
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reduction after receiving HT is limited, but one well-designed study did find decreased 
stress after receiving HT. That particular study examined a group of young college 
students and found that after receiving HT there was an immediate decrease in overall 
stress at the end of the study (Dowd, Kolcaba, Steiner, & Fashinpaur, 2007).  
The assertion of this study is that there are physiological and psychosocial 
stressors related to sickle cell disease pain, which disrupt the natural flow of energy in 
the patient. Healing Touch seeks to use the interaction between man and environment 
to strengthen the internal environment, making it more coherent (consistent) and 
strengthening the lines of defense by balancing the energy field and making it more 
stable in order to maximize the patient’s health potential. This study examined the 
effectiveness of a non-invasive nursing intervention, HT, on anxiety, stress, pain, 
equianalgesic opioid medication, and physiological measures (i.e. blood pressure, heart 
rate, respirations, oxygen saturation, and skin temperature) of hospitalized SCD adults 
experiencing a VOPE. 
 For purposes of this study, the patient population  was SCD adults experiencing 
a VOPE, who were receiving standard care, which is the usual diagnostics, fluids, 
blood, and pharmacological treatments that are typically provided (Yale, Nagib, & 
Guthrie, 2000). Healing Touch, a non-invasive, complementary, energy-based therapy, 
is added to the standard care, to determine the effectiveness of this type of 
complementary treatment option. The addition of therapeutic background music to the 
HT intervention was to address the distraction of ambient noise levels in the acute care 
setting, which have been reported to be in the range of 50-75 dB during the day. The  
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US Environmental Protection Agency (1974) recommends that the noise level of 
hospitals be less than 45 dB during the day.   
The Attention Control Group with Background Music (ACM) 
The ACM group was designed to control for the effect of the music as well as the 
physical presence of the research assistant during the HT intervention. The research 
assistant (RA) in the ACM group remained in the room for the same amount of time as 
in the HT intervention group to account for the physical presence of the healthcare 
provider, while performing a mundane task (i.e. working a cross word puzzle) to control 
the RA from focusing his/her intent on the patient, as would occur in the HT intervention 
group. The same pre-selected music CD was played for both intervention groups to 
control for the music variable.  
 Music is a type of complementary healing therapy that uses an intentional 
auditory stimulus to affect both the patient’s physiological and psychological outcomes 
(Kemper & Danhauer, 2005). Music as a therapeutic intervention has been used in 
various age groups including premature infants (Lorch et al., 1994), children (Malone, 
1996), and adults (Cowan, 1991) for various conditions and procedures. Even though 
numerous studies have shown a decrease in anxiety (Gillen, Biley, & Allen, 2008; 
White, 1992; White, 1999; Wong, Lopex-Nahas, & Molassiotis, 2001) and pain (Nilsson, 
Rawal, & Unosson, 2003; Aragon, Farris, & Byers, 2002; Good, Anderson, Staton-
Hicks, et al., 2002) not all of them reached statistical significance, and therefore the 
relevance for clinical practice is unclear. Bally, Campbell, Chesnick, and Tranmer 
(2003) suggested that music therapy may be more effective in subgroups of patients 
with higher levels of anxiety, stress, or pain like those in this study with SCD. No studies 
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were found using music to reduce anxiety, stress, or pain for SCD adults experiencing a 
VOPE. The purpose of this pilot study was to examine the effectiveness of a non-
invasive nursing intervention, HT, on anxiety, stress, pain, equianalgesic opioid 
medication, and physiological measures (i.e. blood pressure, heart rate, respirations, 
oxygen saturation, and skin temperature) of hospitalized SCD adults experiencing a 
VOPE. The effect of HT on the outcome variables was measured by 1) selected 
physiological parameters, 2) self-reported levels of anxiety, stress, and pain, as well as 
3) equianalgesic opioid medication received during the study period, while controlling for 
the variables music and presence. By comparing both the HTM group and the ACM 
group, the change in the outcome measures between the two interventions can be 
shown to be the result of HT, since the music used to reduce outside distractions and 
the presence of the RA was identical in both groups.  
Effect of Presence 
 The concept of therapeutic presence has entered the mainstream of nursing 
without clear definition and with little critical examination or evidence-based analysis. 
Exactly how therapeutic presence impacts the outcomes seen in complementary 
interventions such as HT or Music is still being addressed in the literature. For this 
study, therapeutic presence is defined as a way of being with another person, fully 
present in body, mind and spirit, open to the situation (Paterson & Zderad, 1976), 
setting intentionality for the patient’s highest good, and developing a trusting 
relationship (McKivergen & Daubenmire, 1994). Having established a therapeutic 
presence between the nurse and the patient, the current literature suggests that this will 
increase patient satisfaction and improve patient outcomes. Osterman and Schwartz-
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Barcott (1996) describe four ways of being present as presence, partial presence, full 
presence, and transcendent presence. It is thought that transcendent presence can 
create a positive change in the affective state, therefore decreasing anxiety because of 
the peaceful, comforting feeling it creates. A review of the literature reveals a general 
consensus that the nurse-patient relationship encountered with the introduction of the 
component of presence is perceived as also having a positive impact on the patients 
and their healing process. Rogers (1996) described these beneficial outcomes for 
patients as feelings of support, hope, relaxation, and the ability to cope better. There is 
little research on exactly how this impacts the physiological outcomes of the patient. 
Since it is believed to occur however, it is necessary to account for its effect on the 
patient, and it was addressed in this study by having a RA “present” during both 
interventions. 
Theoretical Framework 
Betty Neuman’s Health Care System Model was used to develop the theoretical 
perspective for this study on the use of HT as a non-invasive nursing intervention in the 
SCD patient population who were experiencing a VOPE. Using ideas from a variety of 
sources such as the Gestalt theory and the General System theory, Neuman identified 
several major concepts in her model, which creates the foundation for this study. Based 
on Neuman’s theoretical framework, it is postulated that the patient as a system, 
exchanges information and energy through a continuous and dynamic interaction with 
the environment, and that the administration of HT can assist in creating system stability 
and balance, resulting in a homeostatic body system, the reduction of pain, and overall 
wellness (Neuman & Fawcett, 2002; Tomey & Alligood, 2006). 
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In Neuman’s concepts of the “wholistic” patient approach, which included not 
only the whole patient, but an open system, the environment, and stressors, are all 
shown interacting with five components of the patient: physiological, psychological, 
developmental, socio-cultural, and spiritual. This approach shows the components 
intermingling with the patient’s basic structure (i.e. cognitive ability, physical strength, 
and value systems, etc.), lines of resistance (defends against stressors) and lines of 
defense (protects the system’s stability) in order to maintain homeostasis in the system 
(Neuman & Fawcett, 2002). This study did not explore the developmental and spiritual 
components of Neuman’s model. The holistic effect of Healing Touch, which does 
encompass the spiritual aspect of healing, may be present, but for purposes of this 
study was not examined. It is hypothesized however, that using Neuman’s model, the 
SCD patients’ normal line of defense is their usual state of health prior to hospitalization. 
Adjusting this line of defense, which changed in response to their VOPE, is one of the 
mechanisms used to restore their state of equilibrium or balance (George, 2002). 
Healing Touch can assist with balancing the system’s stability by working with the 
energy surrounding the body, utilizing this energy source to impact the environmental 
forces (stressors) which influence their dynamic system as the patient moves towards 
wellness. The SCD patients’ lines of resistance constitute part of their defense 
mechanisms that attempts to address the states (i.e. stress and anxiety) created by 
their internal and external environments, which cause instability. In this study, three of 
the core components, (the physiological, the psychological, and the socio cultural 
component) played a role in determining how SCD patients respond to the stressors 
  13
related to their disease and will ultimately determine their ability to adapt to these 
stressors.  
 A stressor, anything that can affect the stability of the system, can be categorized 
as intrapersonal (occurs within the person), interpersonal (occurs between individuals), 
or extrapersonal (occurs outside the individual) (Neuman & Fawcett, 2002). The 
patient’s reaction to the stressor depends in part on the strength of their lines of 
resistance and defense. According to Neuman’s model, interventions by either the 
patient or the nurse are done to restore or maintain the stability of the system. 
Assessment of the total situation in which the patient presents requires knowing the 
relationship between the internal (forces that affect patients within their system such as 
a VOPE) and external environmental factors (forces affecting patients outside their 
system such as environmental temperatures) as well as the created environmental 
factors (forces created unconsciously by the patient such as anxiety and stress) 
(Neuman & Fawcett, 2002; Tomey & Alligood, 2006). Based on the assessment of 
these stressors, assisting the patient in making adjustments to maintain an optimal level 
of wellness by the use of primary, secondary and tertiary prevention strategies as 
interventions is part of the nursing process (Neuman & Fawcett, 2002). The HT 
intervention served as both a secondary as well as a tertiary prevention strategy in this 
study.    
The patients’ expectations, defined for this study as anxiety about impending 
pain, and the stress created by their lifestyle, influence their lines of defense and 
resistance causing the destabilization of the internal core structure. The hospitalized 
SCD adults often have numerous stressors or disturbances in the lines of defense due 
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to the pathophysiology as well as the psychosocial aspects of their disease (i.e. anxiety 
due to biases of healthcare workers and the isolation experienced) (Elander & Midence, 
1996; Shapiro & Ballas, 1994). By working with the SCD patient’s lines of defense and 
resistance and thereby interacting with their internal and external environments, HT 
improves their defenses against these disturbances, addressing those 
pathophysiological responses caused by increased sympathetic nervous system 
responses (i.e. increase blood pressure, heart rate, respiratory rate, oxygen 
consumption, and decreased skin temperature due to vasoconstriction of blood vessels) 
that result in pain. Healing Touch, which has been shown to reduce psychosocial 
disturbances such as anxiety and stress in other patient populations (Dowd, Kolcaba, 
Steiner, & Fashinpaur, 2007; Hjersted-Smith & Jones, 2006; Welcher & Kish, 2001), 
was postulated to also assist in strengthening the SCD adult’s lines of defense and 
resistance against these disturbances.  
Secondary prevention as described by Neuman is what occurs after the patient’s 
system reacts to a disturbance, in this case the VOPE. The secondary prevention 
attempts to strengthen the lines of resistance so as to help the patient defend against 
disturbances, (e.g. anxiety and stress), resulting in an overall reduction in pain (Neuman 
& Fawcett, 2002). It was proposed that HT, due to its ability to relax, restore, and 
balance the patient’s energy system, would decrease the release of catecholamines 
(physiological stressors) caused by stimulation of the sympathetic nervous system and 
help to prevent additional disturbances that cause the SCD patient’s VOPE. The effects 
of HT as a secondary prevention was postulated to be a decrease in the self-reported 
anxiety, stress, and pain scores as well as changes in the physiological parameters. 
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Tertiary prevention occurs after secondary prevention has been provided. It 
focuses on strengthening the resistance to stress factors or disturbances and 
preventing recurrence of the reaction, thereby providing stability to the system (Neuman 
& Fawcett, 2002). As a tertiary prevention, the accumulative effectiveness of HT was 
hypothesized to result in a decrease in anxiety and stress, as well as decreases in pain 
intensity and longer periods of time between pain events, resulting in a decrease in the 
amount of medication required. In this study, HT was used as a secondary and tertiary 
prevention in the hospitalized SCD adults experiencing a VOPE. Working with the SCD 
patient’s lines of defense and lines of resistance and interacting with their internal and 
external environments, HT, which has been shown to produce relaxation and reduce 
anxiety, was postulated to assist patients in improving their defenses against these 
stress factors and reducing the patients’ reactions to these disturbances (Figure 1).  
 In this study, the proposition of the conceptual framework based on Betty 
Neuman’s Health Care System Model was:  
 If HT in other patient populations has been shown to: 
• Reduce anxiety (a psychological stressor) (Post-White et al., 2003; 
Welcher & Kish, 2001), and 
• Reduce stress (a psychological stressor) (Dowd, Kolcaba, Steiner, & 
Fashinpaur, 2007; Wilkinson et al., 2002), and  
• Reduce pain (a physiological stressor) (Darbonne, 1997; Merritt & 
Randall, 2002; Slater, 1996; Wardell, Rintala, Daun & Tan, 2006),  
• Then HT, through its repatterning of the energy field, will strengthen the 
lines of resistance and the lines of defense, thus reducing the 
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psychologiacal stressors, anxiety and stress, and thereby reducing the 
frequency and severity of the pain experiences in this SCD patient 
population experiencing a VOPE (Platt et al., 1994).   
Conceptual Definitions 
 Healing Touch with background music is a type of non-invasive, complementary, 
energy-based therapy that uses various techniques to work with the energy fields that 
surround the body, re-patterning and re-aligning the fields, thus restoring harmony and 
balance to the human energy system (Mentgen, 2001), while the music is used as a 
distractor for the ambient noise level in the acute care setting.  
 Music is a type of complementary healing therapy that uses an intentional 
auditory stimulus to affect both the patient’s physiological and psychological outcomes 
(Kemper & Danhauer, 2005). 
 Therapeutic presence is a way of being with another person, fully present in 
body, mind, and spirit, open to the situation (Paterson & Zderad, 1976), setting 
intentionality for the patient’s highest good, and developing a trusting relationship 
(McKivergen & Daubenmire, 1994).   
 Physical presence is physically being in the room and communicating with 
another person, but not being present in mind, body, and spirit and not focusing positive 
intent for the other person. 
 Sickle cell disease is inherited as an autosomal recessive trait that is 
characterized by the presence of sickle or crescent shaped red blood cells 
(erythrocytes) in the bloodstream (SCD Association of America, Inc. 2008). 
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 Vaso-occlusive episodes are when sickled red blood cells obstruct blood flow to 
the various organs and tissues, causing the complications associated with SCD such as 
pain, stroke, etc. (Yale, Nagib, & Guthrie, 2000). It is often, but not always, associated 
with objective physical signs of autonomic nervous system activity such as tachycardia, 
hypertension, diaphoresis, mydriasis, and pallor (Godfrey, 2005).   
 Pain is an unpleasant sensory and emotional experience associated with actual 
or potential tissue damage, or described in terms of such damage. (International 
Association for the Study of Pain, 1994) 
 Anxiety is defined as a feeling of nervousness, apprehension, fear, or worry 
characterized by physical symptoms such as palpitations, sweating, and feelings of 
stress (American Academy of Family Physicians, 2009). 
 Stress is defined as the non-specific, tension-producing response of the body to 
any demand for change (Neuman & Fawcett, 2002; Selye, 1974). 
 Basic structure – basic individual survival factors (i.e. heart rate, blood pressure, 
respiratory rate, oxygen saturation, and skin temperature) or energy resources as well 
as other characteristics available to the patient (i.e. cognitive ability or value system) 
(Neuman & Fawcett, 2002). 
 Environment – the factors that affect or are affected by forces, both internal and 
external, to the patient’s system. 
• The internal environment - forces that affect patients within their system.  
• The external environment - forces affecting patients outside their system.  
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• The created environment - forces created unconsciously by the patient and 
represent the patient’s attempt to cope with the stressor in order to maintain system 
wholeness (Neuman & Fawcett, 2002; Tomey & Alligood, 2006).  
 Lines of resistance (LOR) – protects the basic structure, defends against stress 
factors or disturbances (Neuman & Fawcett, 2002). 
 Lines of defense (LOD) – protective buffer against stress factors or disturbances, 
represent system stability over time (Neuman & Fawcett, 2002). 
 Secondary prevention – occurs after the system reacts to a stress factor or 
disturbance and focuses on preventing damage to the basic structure by strengthening 
the internal lines of resistance and/or removing the stress factor or disturbance 
(Neuman & Fawcett, 2002). 
 Tertiary prevention – occurs after the system has been treated through 
secondary prevention strategies and functions to strengthen the resistance to stress 
factors or disturbances and helps prevent recurrence of the reaction (Neuman & 
Fawcett, 2002).  
Operational Definitions 
 Healing Touch energy assessment:  Hand Scanning was used to sense the 
energy, while a pendulum was used to determine flow or spin of the chakra based on 
the speed of  the pendulum, direction of the pendulum movement (i.e. clockwise or 
counterclockwise) and the shape of movement of pendulum (Hover-Kramer, 2002). 
 Pain as measured on the Numeric (pain intensity) Rating Scale (NRS) which 
assess pain intensity on a scale of 0 to 10, with 0 representing no pain to 10 
representing the worst pain ever. 
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 Anxiety as measured by the completion of the Generalized Anxiety Disorder 
Scale (GAD-7), which consists of seven items measured on a four-point response 
scale ranging from 0 (not at all) to 3 (nearly every day). A total score ranging from 0 to 
21, with higher scores associated with greater levels of anxiety. 
 Stress as measured by the Modified Perceived Stress Scale (PSS-10), which 
was a self reporting measure of the perception of stress or the degree to which 
situations in one’s life are appraised as stressful. Measured on a five point Likert scale 
(0 = never, 4= very often) with total scores range from 0 to 40, with higher scores 
associated with greater levels of perceived stress. 
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Figure 1: The Effect of Healing Touch on Anxiety, Stress, Pain, Equianalgesic Opioid Medication, and Selected 
Physiological Parameters in Hospitalized Sickle Cell Disease Adults Experiencing a Vaso-occlusive Episode. 
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Purpose 
 The purpose of this pilot study was to examine the effectiveness of a non-
invasive nursing intervention, HT, on anxiety, stress, pain, equianalgesic opioid 
medication, and physiological measures (i.e. blood pressure, heart rate, respirations, 
oxygen saturation, and skin temperature) of hospitalized SCD adults experiencing a 
VOPE. The effect of HT on the outcome variables was measured by 1) participant’s 
selected physiological parameters, 2) self-reported levels of anxiety, stress, and pain, 
as well as 3) equilanalgesic opioid medication received during the study period, while 
controlling for the variables music and presence.  
Hypotheses 
  Research hypotheses related to the proposed intervention in hospitalized SCD 
adults experiencing a VOPE and who are receiving HTM were to:    
1.  Experience lower blood pressure, heart rate, respiratory rate, and a 
higher oxygen saturation and skin temperature than patients receiving the 
ACM at completion of the interventions day 1, day 2, day 3, and day 4. 
2.    Experience lower anxiety scores than patients receiving the ACM at 
completion of the interventions day 2 and day 4. 
3.         Experience lower stress scores than patients receiving the ACM at 
completion of the interventions day 2 and day 4. 
4.         Experience lower pain scores than patients receiving the ACM at 
completion of the interventions day 1, day 2, day 3, and day 4. 
5.       Require less pain medication than patients receiving the ACM at 
completion of the interventions day 1, day 2, day 3, and day 4. 
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 The above hypotheses were measured by the participant’s self-reported levels of 
anxiety, stress, and pain, as well as changes in the selected physiological parameters 
and the amount of equianalgesic opioid medication used. The relationship between the 
independent variable and the outcome variables, anxiety, stress, pain, equianalgesic 
opioid medication, and the selected physiological measures were examined in this 
parallel-group randomized control trial (RCT) to determine if the main effect for the 
intervention was significant over the four day time period. The data to be analyzed 
were: self-reported measures of anxiety taken from the 7-item Modified Generalized 
Anxiety Disorders scale (GAD-7), stress, taken from the 10-item Modified Perceived 
Stress Scale (PSS-10), pain, taken from the Numeric Rating Scale (NRS), medical 
records documentation of medication usage, and selected physiological data of hospital 
SCD adults experiencing a VOPE. For the anxiety and stress measures, an 
independent sample t-test was used to compare the baseline, day 2 and day 4 mean 
scores between the treatment and control groups. For the pain intensity and 
physiological variables, change scores were computed between pre and post 
intervention at each treatment day, and a paired sample t-test was used to compare the 
mean change at each day between the two groups. A one-way analysis of variance was 
used to compare the total mean equianalgesic opioid medication during the four days of 
the study between the two groups.  In summary, this analysis compared the two 
intervention groups to determine the effectiveness of each in reducing anxiety, stress 
and/or pain and if this change was different between the two study groups over the four-
day period. 
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Gap in the Research  
Most of the research being done in SCD has been conducted to better 
understand the disease process in hopes of being able to find a cure or at least reduce 
the number and severity of its complications. There has been limited research into non-
invasive therapies, except for the work done in cognitive-behavioral therapies (CBT). 
These CBTs have focused on reducing symptoms or on assisting SCD patients in 
coping with the disease. No studies have been found using HT for reducing anxiety, 
stress, pain, and equianalgesic opioid medication usage in the hospitalized SCD adult 
population experiencing a VOPE. The cost of invasive interventions, the risk of 
complications, and the loss of time from work or school to visit healthcare facilities for 
treatments all add to the need for a more cost-effective treatment.  
This research is important because there have been only a limited number of 
well-designed, adequately-powered, clinical trials addressing the effects of HT on the 
patient’s physical outcomes (i. e. anxiety, stress, and pain). Of the work that has been 
done with HT, many of the studies have not been published in peer reviewed, research-
based journals or if published, lacked vital information, resulting in problems with both 
internal and external validity (Wardell & Weymouth, 2004). Some of the studies reported 
small sample sizes, inadequate controls for effects from other variables such as the 
practitioner’s presence, or the placebo effect (Cook, Guerrerio, & Slater, 2004) and 
generally lacked adequate methodological rigor. The research design in the present 
study is an attempt to address these areas of limitations by using an ACM group to 
address the extraneous variable of presence and address the distractors such as 
excessive noise in the acute care setting with the addition of background music. Healing 
   24
Touch is an energy-based therapy, but a quantitative measure of actual energy 
exchange or movement is difficult to obtain. This is why controlling for the variable of 
music and presence will allow the researcher to establish that the only difference in the 
two groups is the HT intervention that was given.  
 Much of the research done in HT has been conducted with cancer, 
cardiovascular, endocrine/ immune/HIV patients and the elderly or dying, looking at the 
reduction of anxiety and pain. What has not been examined is the effect of HT on 
anxiety, stress, pain, equianalgesic opioid medication usage, and physiological 
measures in hospitalized SCD adults experiencing a VOPE. Lastly, since no research 
has been done with HT in the SCD population, the safety of this type of intervention has 
not been determined; therefore this study will contribute to the knowledge about the 
safety of this type of intervention in the hospitalized SCD adult experiencing a VOPE. 
Significance of Study 
 Sickle cell disease is a devastating illness and current management is directed 
toward invasive treatments, which carry many possible complications. The identification 
of a non-invasive, cost-effective, complementary therapy such as HT, adds to the 
various treatment options available to the bedside nurse. Pain, a major distressor in this 
patient population, is under-treated (Jacob, 2001) and has been found to be related to 
an increase in mortality and morbidity (Platt et al., 1994), therefore reducing the number 
of pain episodes and the amount of pain would improve overall patient outcomes. 
Healing Touch has been shown to reduce anxiety, stress, and pain in other patient 
populations; therefore it is hypothesized that it will also reduce these same stressors, 
anxiety and stress, in the hospitalized SCD adults experiencing a VOPE.  
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 Based on findings from previous studies looking at behaviorally based 
psychosocial approaches in the treatment of SCD pain, the importance of this study is in 
determining the effect of HT on anxiety and stress (i.e. psychological  issues) on SCD 
pain and emphasizes the need to quantify the impact of psychological interventional 
strategies in the management of SCD pain. Music is used to provide a distraction to the 
ambient noise level of the acute care setting, but since it is also a psychotherapeutic 
intervention, this effect must be accounted for in order to determine the true effect of the 
HT intervention.  
Summary 
 Healing Touch, a non-invasive nursing intervention, was examined to determine 
its effectiveness on anxiety, stress, pain, equianalgesic opioid medication usage, and 
physiological measures in hospitalized SCD adults experiencing a VOPE. The literature 
reveals that many physical as well as psychosocial factors create stress in the SCD 
patient population, which triggers a SCD pain episode (Edwards, Fillingim, & Keefe, 
2001). By identifying these stress factors, which interrupt the patient’s energy field, HT 
can reorient this energy within the patient’s internal and external environments, thereby 
strengthening their lines of resistance or lines of defense, promoting self-healing and 
wellness. This study examined the effectiveness and safety of the complementary 
therapy, HT, in the hospitalized SCD adult experiencing a VOPE in addressing the 
patient as a whole system. 
  
CHAPTER 2: REVIEW OF LITERATURE 
 The purpose of this pilot study was to examine the effectiveness of a non-
invasive nursing intervention, HT, on anxiety, stress, pain, pain medication usage, and 
physiological measures (i.e. blood pressure, heart rate, respirations, oxygen saturation, 
and skin temperature) of hospitalized SCD adults experiencing a VOPE. The effect of 
HT on the outcome variables were measured by 1) selected physiological parameters, 
2) self-reported levels of anxiety, stress, and pain, as well as 3) equianalgesic opioid 
medication received during the study period, while controlling for the variables music 
and presence.  
 This chapter discusses the relevant literature in each of the three main sections. 
The first section discusses SCD and the problems encountered by SCD adults 
experiencing a VOPE, along with the current treatment options, both pharmacological 
and non-pharmacological, in order to establish why there is a need to evaluate new 
treatment options in this patient population. It also examines the role that stress and 
anxiety play in the SCD adult experiencing a VOPE. The second section looks at 
complementary therapies, specifically the proposed intervention for the study, HT, as 
well as the accumulative effect of the addition of music to the control group. The first 
portion of this section examines Therapeutic Touch (TT), because much of the earlier 
work with energy was done with TT and laid the groundwork for HT. This is followed by 
the current literature on HT and the work that has been done with HT on anxiety and 
stress, as well as pain, in other patient populations such as cancer patients, post-
operative orthopedic and cardiovascular patients. The second half examines the 
literature on music as a healing modality and its effect on anxiety and pain as well as 
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the effect of presence. Finally, the third section of this review explores Betty Neuman’s 
theoretical framework in order to establish the theoretical basis for this study. The 
following review supports the importance of this study because of the limited number of 
non-invasive nursing interventions found in the literature. 
Sickle Cell Disease 
 The management of SCD is targeted toward two aspects of the disease, 
prevention of complications and the management of pain episodes. This study only 
focused on the non-invasive nursing intervention HT with hospitalized SCD adults, 
therefore the management techniques specific to younger children is not discussed. The 
focus of this portion of the literature review, however, is on the treatment options, 
pharmacological and non-pharmacological, specific to relief of the symptoms of 
hospitalized SCD adults experiencing a VOPE.  
 Sickle cell disease (SCD) is a major healthcare problem affecting approximately 
one out of every 375 African-Americans in the United States (Edwards et al., 2005), as 
well as a small portion of the population from the Caribbean, Southern Europe, the 
Mediterranean area, the Middle East, and India (NAHAT, 1991). This worldwide health 
problem affects both men and women of all ages across their entire lifespan. The major 
complication of SCD is the occlusion of the vascular beds and the resultant ischemia, 
which causes the VOPE most often experienced in the back, chest, abdomen, and legs 
(Metha, Afenyi-Annan, Byrns, & Lottenberg, 2006; Steinberg & Brugnara, 2003). The 
optimal management of SCD requires a multidisciplinary team approach due to the 
multidimensional aspect of the reoccurring SCD pain, related to the biological, 
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psychological, behavioral, social, and cultural components of the disease (Yale, Nagib, 
& Guthrie, 2000).  
Sickle Cell Disease – Anxiety and Pain 
Examining pain coping strategies in SCD patients, Gil, Abrams, Phillips, and 
Keefe (1989) found a significant correlation between the psychological distress factors, 
one of which was anxiety and the negative thinking and passive adherence factors to 
the number of pain episodes, their duration, and the severity of pain. These biological 
and psychosocial processes experienced by SCD adults have been shown to cause 
anxiety (Thompson, Gil, Abrams, & Phillips, 1992; Vichinsky, Johnson & Lubin, 1982) in 
regard to their illness. The role of these negative emotions and stressful life experiences 
in the activation of a neurophysiologic stimulus (i.e. anxiety) and the body’s pathologic 
responses in the precipitation, exacerbation, and prolonging of VOPE needs to be 
examined (McCae & Lumley, 1998). It has been documented that anxiety can increase 
pain (Thomas, Heath, Rose, & Fiery, 1995; Thomas, Wilson-Barnett, & Goodhart, 1998) 
and that these negative emotions (i.e. anxiety, stress) can increase pain medication 
usage, visits to the Emergency Departments, and hospitalizations, and that simply 
managing the physical aspects of VOPE will not improve the person’s quality of life (Gil 
et al., 2004). Research on anxiety and its impact on VOPE however, has not been firmly 
established in the literature (Anie, 2005; Leavell & Ford, 1983), which supports the 
premise of this study that stress and anxiety need to be investigated further as to their 
interrelatedness to pain in the SCD patient.  
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Sickle Cell Disease – Stress and Pain 
Pain episodes can be triggered by a variety of causes, such as an infection, 
physical or emotional stress, extreme temperatures, or for no known reason (Steinberg, 
1999). Life stress has been found to markedly increase the probability of developing 
SCD symptoms (Leavell & Ford, 1983). In examining the psychosocial stressors, 
previous research has proposed that increases in stress resulted in increases in pain, 
and that these stressors can be used to predict the onset of pain (Gil et al., 2003; 
Porter, Gil, Carson, Anthony, & Ready, 2000; Porter et al., 1998). Higher levels of daily 
stress were shown to predict pain severity with participants experiencing an average of 
6.5 days with pain and a pain intensity of 4.4 on a 0 to 10-point scale during the painful 
episode (Porter et al., 1998). Looking at whether stress predicts pain, Gil et al. (2004) 
found that there were bi-directional effects indicating that pain leads to fluctuation in 
stress, thereby leading to a subsequent escalation of pain. This study recommended 
that further research be conducted in the relationships of stress and pain to the 
biopsychosocial mechanisms that underlie these stressors, which supports the need for 
the current study. 
 Sickle cell disease patients, a health disparity population, are vulnerable to the 
biases of healthcare providers who fear their potential for addiction (Elander & Midence, 
1996; Shapiro & Ballas, 1994), resulting in inadequate pain management. The 
interruption of normal routines and repeated hospital admissions due to VOPE create a 
stressful time, which can precipitate more pain episodes. These VOPE have been found 
to have a negative impact on patients’ quality of life and increase their overall morbidity 
and mortality (Ballas & Lusardi, 2005). This study suggests that the standard of care for 
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the management of pain in SCD patients should also focus on exploring new treatment 
options for improving the SCD patients’ pain, by addressing both internal and external 
environmental factors such as anxiety and stress as precipitating factors. 
Because VOPE impact patients physically, psychologically, emotionally, socially, 
and financially, there is a need to explore all possible options for treatment of these 
episodes. In this study, the social and financial impacts of SCD were not explored. 
Instead, the effect of Healing Touch on the physiological, psychological, and emotional 
aspects (e.g. anxiety, stress) of SCD patients experiencing a VOPE was examined. 
Current Management of VOPE in Sickle Cell Disease 
 Pharmacological treatment for VOPE. 
 There is currently no standard treatment method for the acute pain episodes of 
SCD; each patient is treated individually. Treatments for sickle cell patients having a 
VOPE focus on treating the physiological aspects with pharmacological methods. In a 
meta-analysis of randomized controlled trials (RCTs) between 1965 and June 2002 
conducted by Dunlop and Bennett (2007), the types of interventions assessed were all 
pharmacological analgesics, including: non-opioid analgesics, weak opioids, and strong 
opioids. Co-analgesics such as corticosteroids, antidepressants, and anticonvulsants 
were also examined in this review. The results of this study revealed that no particular 
analgesic intervention provided complete relief from acute sickle cell pain (Dunlop & 
Bennett, 2007), therefore the most commonly used regimen is:  treating the cause, 
giving analgesic-drug therapy promptly, replacing fluids as necessary, treating the pain 
with opiates, and considering the use of adjunctive therapy such as anti-nausea, non-
steroidal anti-inflammatory drugs or sedatives and anxiolytics (Ballas, 1998; Elander & 
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Midence, 1996). These adjunct therapies are used to increase the analgesic effect of 
opioids, reduce the side effects of primary medications, or manage associated 
symptoms such as anxiety.  
 Another treatment option that has been reported in the literature for VOPE in 
SCD adults is transfusion therapy to treat the hypoxia associated most often with acute 
chest syndrome. Treatment options such as hydroxyurea aim to prevent complications 
by increasing the amount of “good” hemoglobin, hemoglobin F, thereby reducing the 
amount of sickling (Metha et al., 2006; Steinberg & Brugnara, 2003). One final treatment 
discussed is bone marrow transplantation and the transplantation of cord-blood stem 
cells, but the research on these treatment options versus the conventional treatment is 
still fairly new and continues to be studied (Dunlop & Bennett, 2007; Steinberg & 
Brugnara, 2003). Although bone marrow transplantation can be a cure, the availability of 
donors, the complications, and risk involved limit its use. The need to explore new 
treatment options that are non-invasive, that can limit the number of side effects, and 
present minimal risk was one of the reasons for this study.   
 Non-pharmacological treatment for VOPE. 
 Non-pharmacological treatment options being used are: self-hypnosis, 
biofeedback, acupuncture, and transcutaneous electrical nerve stimulation (TENS). The 
findings on the effectiveness of these pain management treatment options were mixed, 
but generally encouraging (Elander & Midence, 1996). The self-hypnosis and 
biofeedback along with progressive muscle relaxation (PMR) and cognitive strategies 
enable participants to raise their peripheral body temperature by visualizing vasodilation 
of peripheral vessels, and have been shown to decrease hospitalizations and 
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medication usage as well as physiological changes which were associated with anxiety 
and pain intensity (Elander & Midence, 1996). The use of non-pharmacological 
treatment methods have shown promise, but again no studies were found using HT in 
relation to anxiety, stress, or pain management in SCD patients.  
  Psychological therapies for SCD. 
 While psychological interventions with SCD patients have yielded encouraging 
results, only a limited number of studies have been conducted on the impact of 
including these interventions in the medical treatment for SCD patients. In a systematic 
review of the literature to determine what research had been conducted on the effects of 
psychological therapies on SCD pain, Anie and Green (2006) found a significant 
reduction in the affective component of pain, providing some evidence for the efficacy of 
psychological interventions in SCD. However, the quality of the studies precluded 
definitive conclusions and more well-designed, adequately powered, multi-center 
randomized controlled trials are needed to assess the importance of psychological 
interventions relevant to the different SCD groups. 
 A literature review by Edwards et al. (2005) describes the pathophysiology of 
SCD. The authors outline the impact SCD has on the public health system and the 
significance of psychosocial issues in the management of the disease. Again, this study 
showed that psychological and social factors contribute to the SCD patient’s complaints 
of pain, and that a more comprehensive approach to the management of SCD pain is 
needed.   
 The analysis of behavioral and interpersonal influences on pain management in 
the literature review by Elander and Midence (1996) showed that patients’ different 
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styles of thinking about pain affected their ability to manage their pain. A 
recommendation for further research in pain management for SCD patients using 
cognitive and behavioral coping strategies to reduce pain was suggested. This supports 
the purpose of this study, which was to examine the effectiveness of a non-invasive 
nursing intervention, HT, on anxiety, stress, pain, pain medication usage, and 
physiological measures (i.e. blood pressure, heart rate, respirations, oxygen saturation, 
and skin temperature) of hospitalized SCD adults experiencing a VOPE.   
  Understanding the dynamic relationship between psychological stressors and the 
pathophysiology of SCD is necessary in order to conceptualize the basic needs of the 
SCD patient. Early intervention on the psychological stressors, anxiety and stress, are 
thought to prevent the manifestations and psychosocial complications in SCD (Edwards 
et al., 2005). In summary, most of the current research on management of SCD is 
looking at invasive techniques such as the administration of high dose IV 
methylprednisolone, IV hydroxyurea, blood transfusions, or bone marrow 
transplantation, which carry much higher complication rates. The focus in non-
pharmacological research has been directed toward cognitive-behavioral techniques, 
primarily coping strategies for the SCD patient. Other non-pharmacological treatment 
options that are currently in use, such as self-hypnosis and thermal biofeedback (Cozzi, 
Tryon, & Sedlacek, 1987), have limited data to support their use, but a few small group 
clinical trials have shown some positive results. No research was found that reported 
the use of Healing Touch for the management of anxiety, stress, and pain in the 
hospitalized SCD adults experiencing a VOPE. 
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Complementary Therapies 
 This next section focuses on the previous research in the area of complementary 
therapies in an effort to establish what work has been done in energy-based therapies. 
The use of complementary and alternative medicine (CAM) has been defined as those 
interventions or health care practices that are not integrated into the predominant 
healthcare model because of societal beliefs and practices (Dossey, Keegan, & 
Guzzetta, 2005). In 1992, The Office of Alternative Medicine (OAM) was created by The 
National Institute of Health (NIH) to evaluate the various types of alternative therapies. 
In 1993, OAM was renamed the National Center for Complementary and Alternative 
Medicine (NCCAM), and its mission is to study CAM therapies being widely used by the 
public to determine which of these therapies are safe, beneficial, and cost-effective. 
CAM therapies are adjuncts to conventional medicine and can allow healthcare 
providers to expand treatment strategies in the care of the patient (NCCAM, 2008). The 
purpose of this pilot study was to examine the effectiveness of a non-invasive nursing 
intervention, HT, on anxiety, stress, pain, pain medication usage, and physiological 
measures (i.e. blood pressure, heart rate, respirations, oxygen saturation, and skin 
temperature) of hospitalized SCD adults experiencing a VOPE. The effect of HT on the 
outcome variables was measured by 1) selected physiological parameters, 2) self-
reported levels of anxiety, stress, and pain, as well as 3) equianalgesic opioid 
medication received during the study period, while controlling for the variables music 
and presence. 
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Complementary Therapy - Therapeutic Touch 
 Healing Touch, which is derived from Therapeutic Touch (TT), uses the concepts 
of energy fields that surround the body, and is an energy-based therapy that can involve 
touching or not touching the patient in order to re-pattern these energy fields. 
Therapeutic Touch is included in this literature review because it laid the groundwork for 
current research in this area of energetic healing and provided the basis for much of the 
HT research that has followed this earlier work.  
 One of the first comprehensive reviews of TT research looked at studies 
conducted between the years of 1974 to 1986 (Quinn, 1988). Quinn examined the 
operational definition of TT along with the theoretical frameworks used to explain and 
predict its outcome. Quinn related that the foundation for future research had been 
established with the consistent expansion of each new study. Quinn examined one of 
the earlier studies (Krieger, 1979), which looked at the effect of TT on hemoglobin in 
hospitalized adults and found a significant increase in hemoglobin in the TT group. 
Another area of research which Quinn examined was studies done by Heidt, Parkes, 
and Quinn, who researched the effect of anxiety on different patient populations to 
determine what effect working with the energy fields using TT had on anxiety. Heidt’s 
experimental study examined anxiety in adult hospitalized cardiovascular patients, while 
Quinn’s experimental study examined anxiety in adult hospitalized cardiovascular 
patients using non-contact TT. Heidt (1981) and Quinn (1982, 1984, 1988b) both found 
a decrease in the level of anxiety in the patient population that was studied. A third 
study by Parkes (1985) found no significant effect of TT on the anxiety level in 
gerontological hospitalized patients compared to those in the control group. 
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In the area of stress, Quinn examined two earlier studies and found differing 
effects on the two patient populations studied. Randolph’s (1979) study on the effect of 
TT on the physiologic response to stressful stimuli in college students showed no 
significant difference between the groups, while Fedoruk’s (1984) quasi-experimental 
study, examined the effect of non-contact TT on neonates’ stress and found significant 
differences in their responses. 
 The last content area examined by Quinn in her review was the effect of TT on 
pain, in which conflicting results were found. Meehan (1985) reported no significant 
differences in pain scores between the intervention and control groups in their adult 
post-operative patients, while Keller and Bzdek’s (1986) experimental study found a 
significant decrease in tension headache pain in adult patients as compared to the 
control group. In summary, based on these early studies, there is a need to continue 
building the body of knowledge about energy medicine like TT and HT in order to better 
understand the effect of this phenomenon. This current study contributes to the body of 
knowledge of the effect of one type of energetic healing practice, HT.  
 More recently, two different meta-analyses of TT were conducted. Peters (1999) 
examined the published evidence supporting TT as a nursing intervention, while 
Winstead-Fry and Kijek (1999) conducted a meta-analyses and an integrative review 
examining research design and outcomes of TT.  In the meta-analysis done by Peters, 
numerous limitations were found, including small sample sizes, which made it 
impossible to accurately identify a statistically significant effect. Four major weaknesses 
were noted that needed to be addressed in future TT research, including: sampling 
procedures (lack of randomization), practitioner skill level, intervention practices (no 
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time limit to the intervention), and the under-reporting of data, which hampered analysis 
and the ability to determine the effectiveness of the interventions.    
 The meta-analysis reported by Winstead-Fry and Kijek (1999) supported the 
findings of Peters. The samples were described incompletely and intervention practices 
varied from study to study, making it impossible to do comparisons. The study did look 
at a meta-analysis on 13 of the studies, which reported means and standard deviations 
of treatment and control groups. On average, a moderate effect size (.39) was noted 
and using the chi-square test, the combined effect was analyzed and found to be 
statistically significant (p < .001), indicating a high degree of variation among the 
studies. The authors noted that without “standardizing the treatment” the researcher 
could be measuring something besides the TT intervention. The authors recommended 
more randomized clinical trials or other outcomes research methodologies, with 
attention to internal and external validity, clear operational definitions and valid, reliable 
measures of the outcomes for TT. The design for this study addressed many of the 
limitations that were identified in this earlier work.     
Complementary Therapy - Healing Touch 
Healing Touch, the intervention for this study, is the focus for the next section in 
this review. Healing Touch is a type of complementary, energy-based therapy that 
works with the energy fields that surround the body, re-patterning and re-aligning the 
fields, thus restoring harmony and balance to the human energy system.  Healing 
Touch was developed in 1980 by Janet Mentgen, BSN, RN (Mentgen, 2001). It began 
as a certificate program sponsored by the American Holistic Nurses Association (AHNA) 
in 1989. In 1993, the AHNA began to provide certification for healing touch practitioners. 
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Then in 1996, Healing Touch International, Inc. became the certifying authority with 
AHNA’s endorsement (HTI, 2007). The certifying board, Healing Touch International, 
uses standardized criteria to acknowledge learning experiences and demonstration of 
competence as a Healing Touch Practitioner (Hoover-Kramer, 2002). In 2007 Healing 
Touch Program (HTP) and Healing Touch International (HTI) split and became two 
separate entities with separate certifying bodies: Certified Healing Touch Practitioner 
(CHTP) from HTI or Healing Touch Certified Practitioner (HTCP) from HTP. 
Research on the efficacy of HT is still very new, and while only about 70-plus 
research-based studies/articles have been published on the effect of HT in the past 20 
years, the research thus far is promising. Healing Touch, a complementary therapy 
derived from Therapeutic Touch, has been shown to decrease anxiety, stress, and pain 
in areas such as cancer, orthopedic, and post-cardiac surgery patients, but no studies 
have been conducted in the area of sickle cell pain. The purpose of this pilot study was 
to examine the effectiveness of a non-invasive nursing intervention, HT, on anxiety, 
stress, pain, pain medication usage, and physiological measures (i.e. blood pressure, 
heart rate, respirations, oxygen saturation, and skin temperature) of hospitalized SCD 
adults experiencing a VOPE. The effect of HT on the outcome variables was measured 
by 1) selected physiological parameters, 2) self-reported levels of anxiety, stress, and 
pain, as well as 3) equianalgesic opioid medication received during the study period, 
while controlling for the variables music and presence.   
 In this study, the proposition for the conceptual framework based on Betty 
Neuman’s Health Care System Model was:  
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 If HT in other patient populations has been shown to: 
• Reduce anxiety (a psychological stressor) (Post-White et al., 2003; 
Welcher & Kish, 2001), and 
• Reduce stress (a psychological stressor) (Dowd, Kolcaba, Steiner, & 
Fashinpaur, 2007; Wilkinson et al., 2002), and  
• Reduce pain (a physiological stressor) (Darbonne, 1997; Merritt & 
Randall, 2002; Slater, 1996; Wardell, Rintala, Daun & Tan, 2006),  
• Then HT, through its repatterning of the energy field, will strengthen the 
lines of resistance and the lines of defense, thus reducing the 
psychologiacal stressors, anxiety and stress, and thereby reducing the 
frequency and severity of the pain experiences in this SCD patient 
population experiencing a VOPE (Platt et al., 1994) 
 Studies of energy-based modalities that have been conducted suggest that 
energetic healing techniques like HT are effective (Engebretson & Wardell, 2007). A 
literature review of published quantitative research on HT from 1996 to June 2003, 
excluding case studies and qualitative works, was conducted by Wardell and Weymouth 
(2004). Thirty-two studies using HT as an intervention were described, but due to 
limitations/weakness in the design and/or methods, the authors reported that the results 
of the studies were promising, but non-conclusive. Many of them lacked vital 
information, resulting in weakness in their internal and external validity. Even though the 
studies were not well designed, HT had an overall effect on levels of stress, anxiety, 
and pain, as well as improved healing and improvement in other physiological 
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parameters. The following is an analysis of the research that has been done with HT in 
the areas of anxiety, stress, and pain. 
 Healing Touch - effect on anxiety and pain. 
 Many of the Healing Touch research studies have been conducted with cancer 
patients and the side effects from cancer treatments.  A randomized crossover 
intervention study by Post-White et al. (2003) examined the effects of HT and 
therapeutic massage on anxiety and pain in 230 chemotherapy patients as compared to 
a caring presence or a standard cancer treatment alone. The authors found a significant 
reduction in immediate pain after the HT session, as well as after the massage 
intervention, but there was no significant difference in the overall pain index one month 
after each intervention. HT and massage therapy (MT) both reduced anxiety during the 
interventions, but only the massage group reached significance. The authors concluded 
that both HT and massage were more effective than the presence of a caring 
professional alone or standard care in inducing a relaxed state and reducing short-term 
pain and anxiety in adult cancer patients undergoing chemotherapy. The authors 
recommended that even though the study provided support for the short-term effects of 
MT and HT, further study is needed to test for long-term effects. In this present study, 
only two of these stressors evaluated above, anxiety and stress, were examined to 
determine their effect on the patient’s ability to reduce pain by strengthening their lines 
of defense during their hospital stay.  
 Several studies (Merritt & Randal, 2002; Slater, 1996; Stouffer, 2004; Welcher 
and Kish, 2001) examining the before and after effect of the HT intervention on either 
anxiety and/or pain reported significantly decreased effects in patients with differing 
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diagnoses. Sixty-two women receiving radiation treatment for breast cancer in a 
randomized controlled trial (Cook, Guerrerio, & Slater, 2004) were given non-contact HT 
or Mock treatments to determine the effect of HT. The HT group reported better 
outcomes with statistically significant differences in the areas of pain in the HT group 
compared to the Mock/control group. The result of this study lends support to the use of 
HT to improve factors such as quality of life and pain in cancer patients.   
 In examining the effect of HT and progressive relaxation on chronic neuropathic 
pain in persons with spinal cord injury, Wardell, Rintala, Daun & Tan’s (2006) pilot study 
looked at twelve participants who were randomly assigned to six sessions with either 
the HT treatment group or the guided progressive relaxation group. A significant 
difference was found in the composite of interference on the Brief Pain Inventory (BPI). 
The reduction in pain was seen in both treatment groups, but the pain intensity returned 
to pretreatment levels before the next session. The authors reported that the HT group 
showed improvement in all outcome measures, but they did not reach significance and 
further studies are needed. 
 Although there was limited research found on the effect of HT on anxiety, the 
studies reported here showed a decrease in anxiety after the HT intervention. Due to 
this limited amount of research, the need for further studies in this area has been 
established.   
 Healing Touch - effect on stress. 
 Wilkinson et al. (2002) conducted a quasi-experimental study examining the 
effect of the nurse practitioner’s training and the effectiveness of HT on the reduction of 
stress in three treatment groups: no treatment (NT), HT only (standard HT care), and 
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Standard HT care plus music and guided imagery, was conducted by using the immune 
function (secretory IgA) as an outcome measure for stress reduction. The results 
showed a statistically significant effect on the reduction of stress levels with both HT 
conditions. Analysis of the qualitative data revealed themes of relaxation, connection, 
and enhanced awareness. One of the limitations noted in this study was that some of 
the practitioners had training in other energy healing modalities such as reiki, and this 
could have influenced the quality of the treatments. 
 Another study looking at stress compared HT and coaching for enhancing holistic 
comfort and reducing symptoms of stress in young college students (Dowd, Kolcaba, 
Steiner, and Fashinpaur, 2007). This experimental study revealed that all groups were 
the same on stress, but after the intervention, the HT group had the greatest percentage 
of decrease in stress, which was statistically significant. The findings revealed that HT 
had a better immediate result on stress and comfort, but that coaching had a better 
long-term effect. Several other studies done with HT looking at it across a time span of 
a week or more (Dubrey, 2003; Dubrey, 2006) reported a reduction in stress as well as 
pain in different patient populations (i.e. recovering from alcoholism, patients in a 
community-based practice). 
 In examining the literature on stress and HT, the results tend to suggest that HT 
does relieve stress even though some of the studies did not reach a statistically 
significant result. Additional studies on the effect of HT on stress need to be conducted 
to determine if reduction of stress will have an effect on the reduction of pain, which was 
the proposition examined in this study with the adult SCD patient population. 
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  In summary, there are many more HT research studies that have been done or 
are currently being conducted in a variety of areas such as: cancer, cardiovascular, 
studies on death, dying, palliative care, the elderly, autoimmune disorders, HIV, 
endocrine problems, orthopedics, patient satisfaction, pediatrics, post operative, and 
psychology. Preliminary work in all these areas lends validity to establishing HT as an 
evidenced based treatment option, but there are still areas to be explored. To date, no 
published research has been found that has addressed the anxiety and stress of SCD 
patients or how reducing these symptoms can impact their pain. The focus of this RCT 
pilot study was to examine the effectiveness of a non-invasive nursing intervention, HT, 
on anxiety, stress, pain, pain medication usage, and physiological measures (i.e. blood 
pressure, heart rate, respirations, oxygen saturation, and skin temperature) of 
hospitalized SCD adults experiencing a VOPE. The effect of HT on the outcome 
variables was measured by 1) selected physiological parameters, 2) self-reported levels 
of anxiety, stress, and pain, as well as 3) equianalgesic opioid medication received 
during the study period, while controlling for the variables music and presence. The 
work with HT in the area of reducing pain has been with patients whose pain typically 
has been either due to cancer or surgical procedures such as that experienced by post-
cardiac surgery patients or post-operative orthopedic patients. Sickle cell disease pain, 
although similar to cardiac disease pain, ischemic in nature, has not been studied. The 
importance of this study in looking at the effect of HT on anxiety, stress, and pain is that 
this type of ischemic pain has not been well studied and no research has been found in 
the literature examining this issue in SCD patients.   
   44
 In addressing the paucity of knowledge in the use of a complementary therapy, 
HT, in the reduction of anxiety, stress, and pain in the hospitalized SCD adult patient, 
this study has the capacity to contribute to the body of knowledge on the effectiveness 
of HT on pain relief in the SCD patient population. The study also provides information 
about the safety of this type of intervention and builds on previous work. 
Complementary Therapy - Music 
Music as a therapeutic intervention has been used throughout the ages from the 
Biblical account of David’s harp music calming Saul (1 Samuel 16:22) to the Greek myth 
of Orpheus and the lyre that Apollo, the god of music, gave him. In Greek mythology, 
music was thought to have the power to help heal the mind, body, and spirit. 
Interestingly, Apollo’s son Aesculapius was the god of healing and medicine (Dossey, 
Keegan, & Guzzetta, 2005).  Music as a nursing intervention began with Florence 
Nightingale when she taught nurses that the effect of music on the sick was usually 
beneficial and could take away nervous irritations (Nightingale, 1860). Even today, 
music therapy, listed as sound energy therapy, sometimes referred to as vibrational or 
frequency therapy has been shown to help reduce pain and anxiety (NCCAM, 2008). 
Music - effect on anxiety and pain. 
Music is a type of complementary healing therapy that uses an intentional 
auditory stimulus to affect both the patient’s physiological and psychological outcomes 
(Kemper & Danhauer, 2005). The psychophysiologic responses created by the 
vibrational aspect of music’s key elements, pitch and rhythm, can influence the limbic 
system (the center of emotions), evoking memories, and stimulating the neurohormonal 
system to release endorphins. Music has been used in various age groups including 
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premature infants (Lorch et al., 1994), children (Malone, 1996), and adults (Cowan, 
1991) for various conditions and procedures. The anxiolytic effect of music is seen as a 
physiological reduction in heart rate, blood pressure, respiratory rate, and oxygen 
consumption due to the release of endorphins and decrease in catecholamine levels 
(Chlan, 1998; Dossey, Keegan, & Guzzetta, 2005; McCaffery & Good, 2000; Updike, 
1990). Music has also been reported to improve motivation, elevate mood, and increase 
feeling of responsibility (Bailey, 1986; Dossey, Keegan, & Guzzetta, 2005).    
 Evans (2002) conducted a systematic review on the effectiveness of music for 
hospital patients and found a total of 19 studies, which demonstrated the effectiveness 
of music for the reduction of anxiety during normal care delivery, but found there was a 
lack of evidence supporting music as an intervention itself. The effect of music on 
anxiety and stress was examined by Updike (1990), who found that after listening to 
music there were significant decreases in one indicator of anxiety and stress, the blood 
pressure, both systolic and diastolic. In a study comparing the effects of progressive 
muscle relaxation (PMR) to PMR with music, and just music therapy alone, it was found 
that all three interventions produced significant changes in anxiety and perceived 
relaxation in the pre/post-test period, but there were no differences among the groups 
(Robb, 2000). More recently, Richards, Johnson, Sparks, and Emerson (2007) 
conducted an extensive review from 1991 to 2004 to identify the clinical benefit of using 
music therapy in the hospital setting, focusing on pain, anxiety, and patient satisfaction. 
The review included ten articles, which supported the potential positive impact of music 
therapy in the health care setting. Six of the articles reported a reduction in the level of 
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anxiety, but only one study, Smolen, Topp, and Singer’s (2002), reached statistical 
significance.   
 In summary, even though numerous studies have shown a decrease in anxiety 
(Gillen, Biley, & Allen, 2008; White, 1992; White, 1999; Wong, Lopex-Nahas, & 
Molassiotis, 2001), but not all of them reached statistical significance. No studies were 
found using music to reduce anxiety, stress, or pain for SCD adults experiencing a 
VOPE. 
Music - effect on pain. 
Music is thought to produce pain relief by facilitating release of endorphins, which 
are the body’s natural opioid pain relievers, or by occupying sensory neurons, blocking 
the transmission of painful messages (Chlan, 1998). A significant difference in pain 
intensity has been shown with the use of music in a study of post cardiac surgery 
patients (Sendelbach et al., 2006) as well as in patients undergoing compression with a 
C-clamp after percutaneous cardiac intervention (Chang, Wong, Chan, et al., 2006). A 
Cochrane review conducted by Cepeda, Carr, Lau, and Alvarez (2006) examined fifty-
one randomized controlled trials evaluating the effect of music on any type of pain in 
children or adults. This review concluded that listening to music does reduce pain 
intensity levels and opioid requirements, but the magnitude of these benefits, even after 
pooling of the studies with clinical and statistical homogeneity, was small, therefore the 
clinical importance is unclear.  
Even though numerous studies have shown a decrease in anxiety, stress, and 
pain, not all of them reached statistical significance. Music therapy’s effectiveness in 
subgroups of patients with higher levels of anxiety, stress, or pain, like those in this 
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study with SCD (Bally, Campbell, Chesnick, & Trannier, 2003), was addressed by 
providing music in both groups. By comparing the HT group with music and presence to 
the control group with music and presence alone, the change in the outcome measures 
between the two groups can be shown to be the result of HT, since the music used to 
reduce outside distractions and the physical presence of the RA was the same in both 
groups. No studies were found using music to reduce anxiety, stress, or pain for SCD 
adults experiencing a VOPE. The intervention piloted for this study was the effect of the 
non-invasive intervention, HT plus music, on anxiety and stress in the reduction of pain 
in hospitalized SCD adults experiencing a VOPE. 
 Presence. 
The concept of presence entered nursing in the early 1960s and has been 
defined by using several different perspectives: a philosophical perspective (based on 
work by Marcel and Heidegger); a social science perspective (having a physical and 
psychological attachment to another, requiring openness between them); and from a 
spiritual ministry perspective for both nursing and non-nursing (Kostovich, 2002; Smith, 
2001). Watson (1985) described presence from her concept of transpersonal caring in 
which there is a human-to-human relationship, where each person is fully present and 
feels a connection between them. Three levels of presence have been described by 
McKivergin and Daubenmire (1994), physical presence, psychological presence, and 
therapeutic presence. The concept of therapeutic presence entered the mainstream of 
nursing without clear definition and with little critical examination or evidence-based 
analysis (MacDonald du Mont, 2002). Exactly how therapeutic presence impacts the 
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outcomes seen in complementary interventions such as HT or music is still being 
addressed in the literature.  
This review will focus on the nursing perspective of therapeutic presence as it 
relates to the nurse-patient relationship. For purposes of this study, therapeutic 
presence is defined as a way of being with another person, fully present in body, mind 
and spirit, open to the situation (Paterson & Zderad, 1976), setting intentionality for the 
patient’s highest good, and developing a trusting relationship (McKivergen & 
Daubenmire, 1994). A review of the literature reveals a general consensus that when 
the nurse-patient relationship is examined using the component of presence, the 
relationship is perceived as having a positive impact on patients and their healing 
process. Osterman and Schwartz-Barcott (1996) describe four ways of being present: 
presence, partial presence, full presence, and transcendent presence. One of these, 
“transcendent presence,” is thought to have a positive change in the affective state, 
therefore decreasing anxiety because of the peaceful, comforting feeling it creates.  
More recently Easter (2000) described four modes of being present: physical, 
therapeutic, holistic, and spiritual. Fredriksson (1999) expands on this concept and 
identifies two sub-concepts of “being there” and “being with.”  “Being there” incorporates 
physical presence and includes communication and understanding, which produces the 
patient outcomes of: a sense of being heard, encouragement, motivation, and 
decreased feelings of loneliness and isolation (Pettigrew, 1990). “Being with” 
encompasses “interpersonal and intersubjective modes of being” that “makes available 
a space where the patient can be in deep contact with his/her suffering, share it with a 
caring other, and find his/her own way forward” (Fredriksson, 1999, p. 1171). Having 
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established a therapeutic presence between the nurse and the patient, the current 
literature suggests that this will also improve patient satisfaction and improve patient 
outcomes. The beneficial outcomes for the patients have been described as feelings of 
support, hope, relaxation, and the ability to cope better (Hines, 1992; Rogers, 1996). 
Much of the research that has been done on presence has been related to the 
interaction between the nurse and the patient. Little research has been done on exactly 
how this interaction impacts the physiological outcomes of the patient. Regardless, 
presence has been identified as an “intense and powerful phenomenon that can make a 
significant difference in the patient’s experience” (Mohnkern, 1992, p. 182). Therefore, 
to account for this powerful effect of presence on the patient, in this study a RA was 
physically present during both interventions. 
Theoretical Framework 
 The theoretical framework chosen for this study was Betty Neuman’s Systems 
Model. Neuman’s model was developed in 1970 as a nursing conceptual model in 
response to a request by graduate students at University of California, Los Angeles 
(UCLA) to help them better understand the concept of a wholistic approach to wellness. 
First published in 1972 as a conceptual framework for examining the interactions 
between people and their environment, Neuman describes this dynamic interaction as 
one in which the patient’s core or basic structure is protected from stressors by their 
lines of defense and resistance (Neuman & Fawcett, 2002). Neuman’s model is based 
on her own philosophical beliefs, clinical experiences, and personal views as well as 
ideas from a variety of sources which Neuman and Fawcett (2002) discuss. Examples 
of some of the various sources are the General System Theory, the Gestalt Theory, 
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portions of de Chardin’s philosophy and Selye’s definition of stress. The General 
System Theory is a process in which living organisms interact with each other and the 
environment (Bertalanffy, 1968). Neuman also used the Gestalt Theory, which deals 
with the process in which an organism maintains its dynamic equilibrium or homeostasis 
(Perls, 1973). Another influenced on Neuman’s work was de Chardin’s philosophy on 
the wholeness of life, which states the parts are determined partially by the whole (de 
Chardin, 2002). In defining stress for her model Neuman used Selye’s (1974) definition 
of stress, the body’s response to any demand made on it. And lastly, Neuman adapted 
Caplan’s (1964) conceptual model of the levels of primary, secondary, and tertiary 
prevention for use in her model. This philosophical approach encompasses the idea of 
wholism, balance, homeostasis, and wellness for the client, all of which are maintained 
by their lines of resistance and defense in response to their environment.    
The environment as defined by Neuman is one having three dimensions: the 
internal environment (found within the patient), the external environment (found outside 
the patient), and the created environment (an environment that is created and 
developed unconsciously by the patient), which surrounds the patient or patient’s 
system. A stressor, anything that can affect the stability of the system, can be divided 
into intrapersonal (occurs within the person), interpersonal (occurs between individuals), 
or extrapersonal (occurs outside the individual). The patient’s reaction to the stressor 
depends in part on the strength of their lines of resistance and defense. According to 
Neuman’s model, interventions by either the patient or the nurse are done to restore or 
maintain the stability of the system. Assessment of the total situation in which the 
patient presents requires knowing the relationship between the internal and external 
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environmental factors as well as the created environmental factors. Based on the 
assessment of these stressors, assisting the patient in making adjustments to maintain 
an optimal wellness level by the use of primary, secondary and tertiary prevention 
strategies as interventions is part of the nursing process (George, 2002; Neuman & 
Fawcett, 2002).     
Neuman describes primary prevention as a type of health intervention given prior 
to the system reacting to a stressor, thereby strengthening the patient’s energy (line of 
defense) and allowing the patient to better respond to the stressor (Neuman & Fawcett, 
2002). Providing primary prevention in the form of HT to strengthen the lines of 
resistance and defense in order to maintain the stability of the system, thereby affecting 
the stressor pain, is one aspect that was not examined in this study, since the 
participants had already reacted to the stressor pain prior to being admitted into the 
hospital.  
Secondary prevention as described by Neuman, however, is what occurs after 
the patient’s system reacts to the stressor. The secondary prevention attempts to 
strengthen the lines of resistance so as to help the patient defend against the stressor 
(George, 2002; Neuman & Fawcett, 2002). The hypothesis that was examined was that 
HT, due to its ability to relax and restore balance within the patient’s energy system, 
would help to decrease the factors (i.e. anxiety and stress) that caused the hospitalized 
SCD adult’s VOPE. The effects of HT as a secondary prevention was demonstrated by 
a decrease in the self-reported anxiety, stress, and pain scores as well as changes in 
the physiological parameters. 
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Tertiary prevention occurs after secondary prevention has been provided. It 
focuses on strengthening the resistance to the stressors and preventing recurrence of 
the reaction, thereby providing stability to the system (George, 2002; Neuman & 
Fawcett, 2002). In this study HT was used as a secondary and tertiary prevention to 
strengthen the lines of resistance and defense in the hospitalized SCD adult 
experiencing a VOPE.  
Neuman’s focus on “prevention as the intervention” (Randell, 1992, p.177) 
supports the premise of this study of introducing HT as a primary or secondary 
intervention aimed at reducing the stress factors (stress and anxiety) in order to affect 
the “client-optimal system stability” (Huch, 1991, p 34). In researching the literature, 
Neuman’s Systems Model was not identified as a conceptual framework for HT, but it 
can be used to explain the effects of stress factors such as anxiety and stress in the 
reduction of pain.  
Knight (1990) used Neuman’s model as the framework to guide the nursing 
practice/care for a multiple sclerosis patient. Due to the unpredictable nature of the 
disease (similar to VOPE in SCD) and its many physiological and psychological 
aspects, this framework assisted the nurse in being able to address the various 
perceptions associated with the disease process, both internal and external. Knight 
stated that besides using Neuman’s model as a means of identifying the stressors, the 
caregiver’s perceptions, and the appropriate interventions, it also offered a means for 
implementing the interventions needed to assist the patients in conserving their energy 
and strengthening their lines of defense and resistance.   
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Neuman’s Systems Model has been used in many different settings to include 
hospitals, rehabilitation centers, nursing homes, hospice centers, as well as to guide 
practice internationally. It has had application in many different areas in nursing from 
research to clinical practice, as well as in education and administration (Alligood & 
Tomey, 2006). However, in conducting this literature review there was only one 
reference that referred to Neuman’s Systems Model with the complementary therapy, 
HT. This was a post hoc integrative theorizing of the research by Dowd, Kolcaba, 
Steiner, & Fashinpaur, (2007) on their Comfort Theory by Kolcaba and Kolcaba (2008). 
The authors discussed Neuman’s model in terms of maintenance as an important 
aspect of “tertiary care.” It is this part of her model that gives insights into maintaining 
stability gained from the treatments given. In this study on the effects of HT on anxiety, 
stress, and pain in hospitalized SCD adults experiencing a VOPE, one assumption is 
that if HT does reduce the anxiety, stress, and ultimately the pain, then this technique 
could be taught to the participants and their families to provide this maintenance of 
stability through the tertiary care provided. 
In summary, Betty Neuman’s Systems Model was selected as the conceptual 
framework for this study based on her idea of the dynamic interaction between people 
and the environment and the mechanisms used (i.e. lines of resistance and defense) to 
protect the system from stressors. Healing Touch works with the energy fields that 
surround the person, similar to Neuman’s description of the dynamic interaction 
between the person and the environment, supporting the body’s natural ability to 
maintain stability, which is comparable to adjusting their lines of resistance and defense 
as depicted by Neuman.
  
CHAPTER 3: METHODOLOGY 
  The purpose of this pilot study was to implement a parallel-group randomized 
control trial (RCT) to examine the effectiveness of a non-invasive nursing intervention, 
HT, on anxiety, stress, pain, pain medication usage, and physiological measures (i.e. 
blood pressure, heart rate, respirations, oxygen saturation, and skin temperature) of 
hospitalized SCD adults experiencing a VOPE compared to a usual care control group 
not receiving the HT intervention.  This chapter is divided into the following sections: 1) 
study participants; 2) sample size determination; 3) study approval procedure; 4) 
research design, 5) instruments; 6) pre-intervention activities; 7) research assistant’s 
training; 8) interventions; 9) random allocation procedure; 10) statistical data analysis; 
11) protection of human subjects; and 12) summary. 
Study Participants 
A convenience sample of SCD adult patients who were experiencing a VOPE 
and had been admitted to a 765-bed, urban not-for-profit health care system was 
approached between 24-48 hours after admission to allow for time for the participants to 
receive initial pain control prior to being asked about enrollment into the study. 
Treatments were given the same day as enrollment.  Inclusion criteria were:  
  1. Age: 18 years or greater  
  2. Male or female 
3. Medically diagnosed with SCD (to include hemoglobin SS, SD, SC 
or sickle-thalassemia)  
4. At least one previous hospitalization for a VOPE within the past 
year 
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5. Admitted for treatment of a VOPE 
6. English speaking     
Exclusion criteria were:  
1. Patients with sickle cell trait instead of SCD 
2. Patients who were admitted to the ICU 
3. Patients who were pregnant 
4. Vulnerable participants (i.e. prisoners or children under the age of 
 18 years)  
5.  Patients hospitalized for more than three days prior to 
 notification of admission 
The age group of 18 years or greater was selected for this study based on the ages of 
SCD patients admitted to the research facility, which was consistent with the national 
average life span expectancy for SCD patients, which ranges up to the age of 48 years 
(Platt et al. 1994). This study only examined adults because of the strict regulations 
concerning the use of children in clinical trials. 
Sample Size Determination 
 The predicted number of patients available over the five-month data collection 
time frame determined the proposed sample size for this study, 20 in each group. A 
sample size of 20 is a minimum recommendation (Tabachnik & Fidell, 2001), and would 
only detect a moderate to large effect size. As Cohen (1988) noted, in new areas of 
research inquiry, effect sizes are likely to be small.  
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Study Approval Procedure 
The Research Coordinator (RC) contacted the Chief Nursing Officer and the 
Nursing Research Sub-council at the facility where the research study was conducted 
and asked for support for the study. Once approval and support was obtained, the RC 
sought approval from the University and Medical Center Institutional Review Board 
(UMCIRB) of East Carolina University and the Institutional Review Board (IRB) at the 
participating research facility in southeastern North Carolina.  
Research Design 
 A parallel-group randomized control trial (RCT) was designed to test effects of 30 
minutes of healing touch with music (HTM) versus an attention control group with music 
(ACM), given daily over four consecutive days.  A four-day time frame was chosen 
based on the results of a previous RCT done by Cook, Guerrerio, and Slater (2004) 
looking at HT and the quality of life in women receiving radiation treatments for cancer. 
The authors stated that the effects of HT are believed to be cumulative over time and 
based on the authors’ clinical experience and resources; HT was given over 6 weekly 
sessions. This study showed HT produced statistically significant results in improving 
the women’s vitality, pain, and physical functioning. Post-White et al. (2003) noted that 
the HT intervention appeared to exhibit a consistent effect over a four-week period in 
cancer patients. Based on the premise that HT has cumulative effects, and these effects 
appear to be consistent, along with the anticipated length of stay for sickle cell patients 
in the research facility, four daily intervention treatments were done to insure that the 
participants would be available to participate during the entire study time. The use of 
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one therapeutic musical selection to mask the environmental distractions was employed 
for the HT interventions in an effort to control for the environmental noise. 
 The independent variable Healing Touch was studied to determine its effect on 
the following outcome variables: 
1. Anxiety  
2. Stress 
3. Pain  
4. Pain medication usage  
5. Selected physiological measures  
• Heart rate 
• Respiratory rate 
• Blood pressure 
• Oxygen saturation 
• Skin temperature (taken from index finger of dominant hand) 
 The data for anxiety and stress were collected prior to the first intervention and 
again after the intervention on days 2 and 4 (Figure 2). The pain scores and selected 
physiological measures were obtained before and after each intervention on all four 
days (Figure 3). Data for the amount of medication used was collected by retrospective 
chart review for each day the intervention was given. Additional demographic 
information (Appendix A) was collected to assess the similarity of the randomly formed 
groups. 
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Figure 2: Experimental Pretest-Posttest Design for Anxiety and Stress 
 
        Day 1                     Day 2                  Day 3                  Day 4 
HTM Group         R –O–X                   X–O                      X                      X–O  
ACM Group       R –O–X                   X–O                      X                      X–O 
R = randomization; X = treatment; O = observation/assessment 
 
Figure 3: Experimental Pretest-Posttest Design for Numeric Rating Scale and 
Physiological Measures  
 
           Day 1                     Day 2                  Day 3                  Day 4 
HTM Group          R –O–X–O               O–X–O               O–X–O               O–X–O  
ACM Group        R –O–X–O               O–X–O               O–X–O               O–X–O 
R = randomization; X = treatment; O = observation/assessment 
 
Instruments 
 To assess for the physiological, psychological, and socio-cultural aspects of the 
sample participants the following questionnaires: Modified GAD-7, Modified PSS-10, 
NRS and selected physiological data, as well as demographic questionnaires were 
completed. The additional selected physiological measures of heart rate, blood 
pressure, and oxygen saturation were taken using GE Medical System’s Dinamap 
portable vital signs machine. The skin temperature was recorded using the Stress 
Thermometer SC911. The respiratory rate was counted for one minute and recorded as 
well, and all measures were collected prior to and after each HTM or ACM interventions. 
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The research coordinator contacted the authors of the instruments used and obtained 
permission to use the tools with the modifications made for this study. These 
instruments were chosen to establish the effectiveness of a non-invasive nursing 
intervention, HT, on anxiety, stress, pain, pain medication usage, and physiological 
measures (i.e. blood pressure, heart rate, respirations, oxygen saturation, and skin 
temperature) of hospitalized SCD adults experiencing a VOPE. 
  The Generalized Anxiety Disorder Scale (GAD-7) consists of seven items 
measured on a four-point response scale ranging from 0 (not at all) to 3 (nearly every 
day). A total score is derived from summing across the seven items, resulting in 
potential scores ranging from 0 to 21, with higher scores associated with greater levels 
of anxiety. The developers of the new scale (Spitzer, Kroenke, Williams, & Löwe, 2006), 
selected nine items from the criteria for GAD listed in the Diagnostic and Statistical 
Manual of Mental Disorders, 4th Edition (DSMD-IV), along with four more items based 
on reviews of existing anxiety scales. This led to a 13-item questionnaire that asked 
patients how often they were bothered by each symptom during the previous two 
weeks: "not at all", "several days", "more than half the days", or "nearly every day"; 
these were scored 0, 1, 2, or 3, respectively. The questionnaire was administered to 
2740 patients situated at 15 primary care clinics in the USA. Of these patients, 965 had 
a telephone interview with a mental health professional - either a PhD clinical 
psychologist or a senior psychiatric social worker. The professionals made independent 
diagnoses with estimates of severity.  The scores of the 13-item questionnaire were 
compared with the professionals' diagnoses, and the best matching seven items were 
selected for the final scale, which was called the GAD-7. Analyses of sensitivity and 
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specificity were done. They showed that a score of 10 or more on the GAD-7 
represented a reasonable cut point for identifying cases of GAD. The sensitivity at this 
level was 89%, and the specificity was 82% - quite satisfactory. Cut points of 5, 10, and 
15 may be interpreted as representing mild, moderate, and severe levels of anxiety on 
the GAD-7.  
 The GAD-7 was chosen for this study because of its usefulness in assessing 
anxiety in both males and females, as well as younger and older patients (Löwe et al., 
2008). The GAD-7 was analyzed using a 2-week time frame, however for this study it 
was modified to assess the change in anxiety over time (2 & 4 days) in a hospital 
setting. Construct validity of the GAD-7 was also demonstrated by Spitzer, Kroenke, 
Williams, and Löwe (2006) to be strongly associated with general health perceptions, 
functional impairment, and bodily pain, which usually exists in SCD patients (Gil et al., 
2004) and can affect their clinical outcomes. 
 The PSS-10, modified for this study, was developed by Cohen and Williamson 
(1988), and is a widely used psychological instrument for measuring the perception of 
stress. It is a measure of the degree to which situations in one’s life are appraised as 
stressful. Items were designed to identify how unpredictable, uncontrollable, and 
overloaded respondents find their lives. The scale also includes a number of direct 
queries about current levels of experienced stress. The PSS-10 was designed for use in 
community samples with at least a junior high school education. The items are easy to 
understand, and the response alternatives are simple to grasp. Moreover, the questions 
are of a general nature and hence are relatively free of content specific to any 
subpopulation group. The questions in the PSS-10 ask about feelings and thoughts 
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during the last month. However, the test-retest reliability analyses for the PSS using a 
shorter time frame (two days) have been shown to have substantial correlations 
(Cohen, Kamarck & Mermelstein, 1983). For this study, the PSS-10 was evaluated at 
two days and again at 4 days to determine whether there was a change in stress levels 
related to the intervention or control group. Each PSS item was measured on a five 
point Likert scale, with responses ranging from never (0) to very often (4).  A total score 
was obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the four 
positively stated items (items 4, 5, 7, & 8) and then summing across all scale items 
(Cohen & Williamson, 1988).  Total scores range from 0 to 40, with higher scores 
associated with greater levels of perceived stress. 
 The Numeric (pain intensity) Rating Scale (NRS) was used to assess pain 
intensity in this study. It employs a rating of pain on a scale of 0 to 10, with 0 
representing no pain to 10 representing the worst pain ever. The NRS, considered a 
self-reported pain assessment tool, is recommended by the Society of Critical Care 
Medicine (Jacobi et al., 2002) and is used broadly in the clinical setting (Sessler, Grap, 
& Ramsay, 2008). 
The NRS has been shown to be highly correlated (r=0.85) with the Visual Analog 
Scale (VAS), another documented pain assessment tool, supporting its validity (Paice & 
Cohen, 1997). Another study found a strong correlation between the VAS and the NRS 
measured at different time points (r = 0.77-0.89); however, a limitation of this study was 
that the sample size was small (n=15) (Wilkie, Lovejoy, Dodd, & Tesler, 1990).  The 
NRS was used in this study to determine pain scores because this is the instrument 
currently in use at the facility where the research was conducted.  
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A retrospective chart review of medication usage was analyzed and the oral and 
parenteral pain medications was standardized for comparison by converting commonly 
prescribed doses into standard morphine equivalents using The Hopkins Opioid 
Conversion Program (Grossman, Nesbit, & Loscalzo, 2003). The overall pain 
medication usage and response was retrieved from the medical record upon discharge 
from the hospital for each day the treatment intervention was given. This information 
retrieved from the chart review was analyzed and a comparison made in total pain 
medication usage between the two groups for the study period.  
The demographic data collected was used to determine if the two intervention 
groups were similar. The data collected included: age, sex, ethnicity, co-morbidities, 
number of previous hospitalizations for VOPE, pain management techniques, and 
whether the participant had experienced a HT or Music session previously.   
Pre-Intervention Activities 
Once IRB approval (see Appendix F) was obtained, the RC met with the Nursing 
Research Sub-council, as well as the Nursing Leadership and the Medical Staff to 
coordinate education of the staff about the study and to provide informational flyers that 
were posted. After notifying the various departments who were involved, all personnel 
assisting in the study were contacted and a meeting convened to discuss the RAs roles. 
Educational sessions were conducted to train the RAs in their roles, whether directly or 
indirectly involved in the study. Upon completion of this education, a final meeting was 
conducted to address issues that emerged during the educational process.  
After all approvals were obtained, a start date was determined and appropriate 
staff notified by email, telephone, or personal communication. The Bed Placement 
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Coordinator, Case Managers, or nursing staff notified the RC of all SCD admissions via 
cell phone. The RC contacted the unit and verified whether the patient met criteria for 
admission to the study and whether the patient’s physician had given permission to 
approach the patient. If the patient met criteria and the physician had given permission, 
the RC approached the patient after the first 24 to 48 hours about the study, explained 
its purpose, and answered any questions. If the patient agreed to participate, an 
informed consent was signed and a copy given to the participant. 
Research Assistant’s Training 
The HT Research Assistants (HT-RAs) who administered the HT sessions had 
completed the NIH Protecting Human Research Participants course modules and were 
either a certified Healing Touch Practitioner (CHTP), a Healing Touch Practitioner 
(HTP), or a Healing Touch Practitioner Apprentice (HTP-A). Prior to the study, the HT-
RAs had completed at least through Level IV of classroom instruction, which consists of 
a total of 103.7 continuing education hours of classroom instruction in HT. The HT-RA 
was trained in the use of the study HT protocols (Appendix D) prior to providing the HT 
sessions by viewing a videotape of the protocols and training sessions. Inter-rater 
reliability was conducted by four observations of the HT-RA to ensure consistency with 
the HT protocols (Appendix E).     
The ACM-RAs who administered the ACM sessions were nurses who completed 
the NIH Protecting Human Research Participants course modules and have were 
trained on the ACM protocols. The ACM-RA introduced his/her self and assisted the 
patient in getting comfortable for the session (i.e. straightening the covers or placing a 
blanket over the patient). Next, the ACM-RA placed the disposable covers over the ear 
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pieces of the headphones, assisted the participant with putting them on, and then 
played the pre-selected music CD for the ACM session. While present in the room with 
the participant, ACM-RAs were instructed to sit quietly and perform a mundane task (i.e. 
working a cross word puzzle) while the session took place to control the ACM-RA from 
focusing their intent on the patient, as would occur in HT intervention. After the 30-
minute session was complete, the ACM-RA turned off the CD, removed the 
headphones, threw away the covers, wiped down the headphones, and returned them 
to the research box.  
The seven Data Collector RAs (DC-RAs) for this study were individuals who 
completed the NIH Protecting Human Research Participants course modules, and were 
nurses other than the HT-RAs or ACM-RAs who administered the treatment, who were 
trained in how to administer the anxiety (Appendix B), stress (Appendix B), and the pain 
(Appendix C) questionnaires, as well as how to obtain the physiological data before and 
after each HTM or ACM session. The DC-RAs were different from the RAs 
administering the interventions to decrease the chance of bias in the data collection.  
 Interventions 
HTM day 1 
 
  Ten minutes before the HTM intervention began, the Modified GAD-7, the 
Modified PSS-10, the NRS, as well as the participant’s physiological data (blood 
pressure, pulse, respirations, oxygen saturation, and skin temperature) were collected 
by the DC-RA. After completion of the pre-treatment data collection, the HT-RA entered 
the room, made the participants comfortable, turned off all distractions (i.e. TV, radio, 
phones) closed any window curtains, and placed a sign on the door indicating that the 
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HT session was in progress. Before the HT intervention began, the HT-RA insured that 
the participant was as comfortable as possible, assisted him/her with putting on the 
headphones, and then started the pre-selected music CD. The HT-RA then provided the 
HT intervention following the HT protocols (Appendix D). At the completion of the 30-
minute session, HT-RA removed the headphones, cleaned the equipment, left the room, 
and notified the DC-RA that the HT session was completed. The DC-RA then entered 
the room and immediately (within 5 minutes) began the collection of pain intensity and 
physiological data. 
ACM day 1 
 Ten minutes before the ACM intervention began, the Modified GAD-7, the 
Modified PSS-10, the NRS, as well as the participant’s physiological data (blood 
pressure, pulse, respirations, oxygen saturation, and skin temperature) were collected 
by the DC-RA. The ACM-RA entered the room, made the participant comfortable, 
turned off all distractions (i.e. TV, radio, phones) closed any window curtains, and 
placed a sign on the door indicating that the music session was in progress. The ACM-
RA insured that the participant was as comfortable as possible, assisted him/her with 
putting on the headphones and then played a music CD with the same pre-selected 
music as the HT intervention group for 30 minutes. The ACM-RA remained present in 
the room throughout the entire session and performed a mundane task (i.e. working a 
cross word puzzle) to control the ACM-RA from focusing his/her attention on the 
participant as occurred in HT intervention. At the completion of the 30-minute session, 
the ACM-RA removed the headphones, cleaned the equipment, answered any 
questions that the participant had, and notified the DC-RA that the ACM session was 
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completed. The DC-RA then entered the room and immediately (within 5 minutes) 
began the collection of pain intensity and physiological data. 
 HTM days 2 - 4  
 Ten minutes before the HTM intervention began at days 2 – 4, the DC-RA 
collected pain intensity and physiological data from the patient. After completion of the 
pre-treatment data collection, the HT-RA made the participants comfortable, turned off 
all distractions (i.e. TV, radio, phones) closed any window curtains, and placed a sign 
on the door indicating that the HT session was in progress. Before the HT intervention 
began, the HT-RA insured that the participant was as comfortable as possible, assisted 
him/her with putting on the headphones and then started the pre-selected music CD. 
The HT-RA then provided the HT intervention following the HT protocols (Appendix D). 
At the completion of the 30-minute session, the HT-RA removed the headphones, 
cleaned the equipment, answered any questions that the participant had, and notified 
the DC-RA that the HT session was completed. The DC-RA then entered the room and 
immediately (within 5 minutes) began the collection of pain intensity and physiological 
data (days 2 – 4), and anxiety and stress scores (days 2 and 4). After completion of the 
post-treatment data collection on day 4, the HT-RA reentered the room and thanked the 
participant for participating in the study, and then asked the participant for questions  
and feedback about the experience. 
ACM days 2 - 4  
 Ten minutes before the ACM intervention began at days 2 – 4, the DC-RA 
collected pain intensity and physiological data from the patient. The ACM-RA entered 
the room, made the participant comfortable, turned off all distractions (i.e. TV, radio, 
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phones) closed any window curtains, and placed a sign on the door indicating that the 
music session was in progress. The ACM-RA insured that the participant was as 
comfortable as possible, assisted him/her with putting on the headphones and then 
played a music CD with the same pre-selected music as the HT intervention group for 
30 minutes. The ACM-RA remained present in the room throughout the entire session 
and performed a mundane task (i.e. working a cross word puzzle) to control the ACM-
RA from focusing his/her attention on the participant as occurred in HT intervention. At 
the completion of the 30-minute session, the ACM-RA removed the headphones, 
cleaned the equipment, answered any questions that the participant had, and then 
notified the DC-RA that the ACM session was completed. The DC-RA then entered the 
room and immediately (within 5 minutes) began the collection of pain intensity and 
physiological data (days 2 – 4), and anxiety and stress scores (days 2 and 4). After 
completion of the post-treatment data collection on day 4, the ACM-RA reentered the 
room and thanked the participant for participating in the study, and then asked the 
participant for questions and feedback about the experience. 
Random Allocation Procedure 
 Once the consent had been signed, all the baseline data were collected before 
the participants were randomized into a group. The participants were allocated to a 
treatment (HTM) or control (ACM) group by using a permuted block randomization 
scheme (Beller, Gebski, & Keech, A.C., 2002; Polit & Beck, 2008) to ensure an equal 
number of patients in each group. The block size was four, with a random sequence of 
four digits (1, 2, 3, and 4) computer generated for each block. Ten blocks was 
generated, resulting in a total of 40 randomly generated digits. Even numbers assigned 
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the participant into the HTM group, while an odd number assigned the participant into 
the ACM group. Each block of four numbers was placed in a separate envelope, sealed, 
and the envelope labeled set 1, 2, 3 . . . 10. After the first participant was enrolled and 
the baseline data had been collected, the RC selected an envelope out of a box and 
assigned that participant to the ACM group if the first random digit was odd (1 or 3), or 
to the HTM group if the first digit was even (2 or 4). For the second participant, the RC 
looked at the second randomized digit in the first envelope, and then placed the second 
patient in either the HTM group or ACM group depending on whether the digit was odd 
or even. This process continued for the third and fourth patients, resulting in exactly 2 
patients randomly assigned to the HTM group and 2 patients randomly assigned to the 
ACM group. When this first block of numbers had been used, then the RC repeated the 
same procedure until all the envelopes had been opened and the 24 study participants 
had been assigned to the two groups. 
Statistical Data Analysis 
 All study data were entered into PASW Version 17. All variables were checked 
for out-of-range values. All the quantitative variables were checked for outliers and 
degree of skewness by examining the histograms of each variable. A one-way analysis 
of variance was used to compare the baseline anxiety, stress, pain severity, and 
physiological variables between the HTM and ACM groups. For the anxiety and stress 
measures, an independent sample t-tests was used to compare the baseline, day 2 and 
day 4 mean scores between the treatment and control groups. For the pain intensity 
and physiological variables, change scores were computed between pre and post 
intervention at each treatment day, and a paired sample t-test was used to compare the 
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mean change at each day between the two groups. A one-way analysis of variance was 
used to compare the total mean pain medication usage during the four days of the study 
between the two groups.  All statistical significance was based on a p-value less than 
0.05. 
Protection of Human Subjects 
 East Carolina University’s Institutional Review Board (IRB) and the IRB at the 
participating research facility approved the research study. A signed informed consent 
for participation in the study was obtained. To ensure the safety of the participants and 
address any foreseeable physical, psychological, economic, social, legal, and dignitary 
risks to the participants the following process was followed. All patients enrolled in the 
study continued to receive the standard of care for their sickle cell disease along with a 
HTM or ACM session. However, the effect of a HT session could possibly create some 
emotional reactions. The process of clearing the congested areas may result in clearing 
away emotional congestion as well as energy congestion. This could create some 
discomfort as bad memories or events emerge that need addressing during a session. 
Any issues identified were shared with the patient’s healthcare provider for follow-up. In 
the pretreatment period, the HT-RA discussed with the patient the intent of the session 
based on the assessment done and any concerns either the HT-RA or participant had 
were addressed. The RC or any RA, along with the staff nurses on the units and the 
participants’ physicians, monitored the participants during the study. If they determined 
that the HT sessions should be stopped or if the participants requested to stop, the 
participants were withdrawn from the study.  
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 The participant’s anonymity was maintained throughout the study by the process 
of coding all data collected with 5-digit alphanumerical identifiers. The RC was 
responsible for this process to prevent any possible identification of the participants. 
Confidentiality was maintained, since only those persons directly involved in the 
research had access to the data for purposes of performing analysis. Any information 
used for the purposes of publication was coded so as to protect participants’ 
identification. Any data collection forms or other information collected during the study 
are preserved and archived in the RC’s office in a locked file cabinet until the end of the 
research project or such time that the data is no longer needed. The RC will then shred 
all data.   
 The anticipated benefit of the research study to participants or others is that it 
adds to the body of knowledge of baseline data for the overall effectiveness of the HT 
therapy. It also provides information about the effectiveness of the survey tools chosen 
for the research study on the application of HT to sickle cell patients.  
Summary 
 
 This chapter described: 1) study participants; 2) sample size determination; 3) 
study approval procedure; 4) research design, 5) instruments; 6) pre-intervention 
activities; 7) research assistant’s training; 8) interventions; 9) random allocation 
procedure; 10) statistical data analysis; and 11) protection of human subjects used for 
this study in order to address the research questions posed. This parallel-group 
randomized control trial (RCT) was designed to test the effectiveness of a 30 minute 
non-invasive nursing intervention, HT, given daily for four consecutive days, on anxiety, 
stress, pain, pain medication usage, and physiological measures (i.e. blood pressure, 
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heart rate, respirations, oxygen saturation, and skin temperature) of hospitalized SCD 
adults experiencing a VOPE as compared to an usual care control group not receiving 
the HT intervention. This design was chosen to address previous limitations in this area 
of research.  
 
               
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER IV: FINDINGS 
 
 The purpose of this pilot study was to examine the effectiveness of a non-
invasive nursing intervention, HT, on anxiety, stress, pain, pain medication usage, 
and physiological measures (i.e. blood pressure, heart rate, respirations, oxygen 
saturation, and skin temperature) on hospitalized SCD adults experiencing a VOPE. 
The effect of HT on the outcome variables was measured by 1) selected 
physiological parameters, 2) self-reported levels of anxiety, stress, and pain, as well 
as 3) the amount of equianalgesic opioid medication equivalents received during the 
study period, while controlling for the variables of music and presence. 
 The research hypotheses that were explored related to the proposed 
intervention in hospitalized SCD adults experiencing a VOPE were those 
participants who received HTM would:    
1. Experience lower blood pressure, heart rate, respiratory rate, and a 
higher oxygen saturation and skin temperature than patients receiving 
the ACM at completion of the interventions on day 1, day 2, day 3, and 
day 4. 
2.    Experience lower anxiety scores than patients receiving the ACM at 
completion of the interventions on day 2 and day 4. 
3.            Experience lower stress scores than patients receiving the ACM at 
completion of the interventions on day 2 and day 4. 
4.            Experience lower pain scores than patients receiving the ACM at 
completion of the interventions on day 1, day 2, day 3, and day 4. 
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5.            Require less pain medication than patients receiving the ACM at 
completion of the interventions on day 1, day 2, day 3, and day 4. 
 The assumption made by the study hypotheses was that the scores for pain, 
anxiety, stress, and physiological measures for the HTM group, when compared to 
the ACM group, would show greater improvement with respect to the pre- to post-
intervention change at days 1, 2, 3, and 4. Another assumption was that the effects 
reflected in the score changes would be of a low to moderate effect size.  Detecting 
whether these low to moderate effects would be statistically significant would require 
a relatively large sample size.  Due to the slow enrollment of study participants into 
the RCT over the past six months, data on the 24 participants (12 in the HT group 
and 12 in the ACM group) was analyzed for this dissertation. This small sample size 
has reduced the power of the statistical methods used to detect statistically 
significant differences between the HTM and ACM groups. This chapter contains the 
sample description, statistical tests used, analysis, and data results obtained during 
the exploration of the previously stated research hypotheses. 
Description of Sample 
 A total of 70 patients were assessed for eligibility for the study. The participants’ 
flow through the study from assessment to final randomization is detailed in Figure 
1. Forty-six participants were excluded from the study for the following reasons: 
seven did not meet inclusion criteria (i.e. admitted to ICU or pregnant), 22 refused to 
participate, and 17 were excluded for other reasons (i.e. admitted for greater than 
three days before notification of admission). The final study sample was comprised 
of 24 participants who ranged in age from 22 years to 49 years with an average age 
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of 31.4 years. Of the 24 participants who started the study, only 16 completed all 
four treatment sessions ( Figure 4). 
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Figure 4  Flow of Participants through study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
  
Assessed for eligibility (n = 70) 
Enrollment 
Excluded (n = 46) 
 
Not meeting inclusion criteria 
(n = 7) 
 
Refused to participate 
(n = 22) 
 
Other reasons 
(n = 17) 
 
Randomized 
Allocated to HTM intervention 
(n = 12) 
 
Received allocated intervention 
Day 1    n = 12 
Day 2    n = 12 
Day 3    n = 11 
Day 4    n = 10 
 
Did not receive allocated intervention 
(n = 2) 
Reasons:  
   Discharged - did not complete study 
(n = 2) 
 
Participant receiving both sessions  
(n=6) 
Allocated to ACM intervention 
(n = 12) 
 
Received allocated intervention 
 Day 1    n = 12 
 Day 2    n = 10 
Day 3    n = 9 
Day 4    n = 6 
 
Did not receive allocated intervention 
(n =6) 
Reasons:  
   Discharged - did not complete study 
(n = 5) 
     Dropped out of study 
(n = 1) 
 
Participant receiving both sessions  
(n=6) 
 
Completed treatment from 
day 1 through day 4 and 
Analyzed (n = 10) 
Completed treatment from 
day 1 through day 4 and 
Analyzed (n = 6) 
Total Sample Size which 
completed all 4 sessions 
(n =16) 
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Descriptive Statistics 
Descriptive statistics (means, standard deviations, percentages) were used to 
examine the demographic characteristics of the two study groups (Table 1). The chi-
square test for independence was used to detect differences between the study 
groups. The average age of the HTM participants was 31.5 (ranging from 22 – 44) 
and 31.3 for the ACM group (ranging from 22 – 49). There were no statistically 
significant differences in age, gender, ethnicity, type of SCD, and number of co-
morbidities between groups. The proportion of females in the ACM group (92%) was 
larger than in the HTM group (50%), and the ACM group had a larger proportion of 
subjects with no co-morbidities (42%) than the HTM group (8%). Fifty-eight percent 
of the participants reported using a complementary therapy (i.e. HT or Music) prior to 
the study to address pain, anxiety, and stress, with the majority stating that the 
complementary therapy did seem to help them to relax.  
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Table 1 
 
Demographic Characteristics of the Study Sample (n=24)  
     
  HTM  ACM Total N 
Age     
   20-30 years  7 (58.3%) 8 (66.7%) 15 (62.5%)  
   31-40 years  2 (16.7%)  0 (.0%)  2 (8.3%) 
   41-50 years   3 (25%) 4 (33.3%)   7 (29.2%) 
     
Gender     
   Male  6 (50%)  1 (8.3%)   7 (29.2%) 
   Female   6 (50%) 11 (91.7%) 17 (70.8%) 
     
Ethnicity      
   African-American  12 (100%)  11 (91.7%) 23 (95.8%) 
   Mediterranean/Middle East     0 (0%)  1 (8.3%)   1 (4.2%) 
     
Type of SCD    
   Hemoglobin SS  7 (58.3%) 8 (66.7%) 15 (62.5%) 
   Hemoglobin SC  3 (25%) 4 (33.3%)   7 (29.2%) 
   Sickle-thalassemia    1 (8.3%) 0 (.0%)  1 (4.2 %) 
   Missing data   1 (8.3 %) 0 (.0%)   1 (4.2%) 
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Table 1 continued    
Demographic Characteristics of the Study Sample (n=24)  
     
     HTM    ACM    Total N 
Co-morbidities     
   None      1 (8.3%) 5 (41.7%) 6 (25%) 
   Smoker  3 (25%) 0 (.0%) 3 (12.5%) 
   Diabetes  1 (8.3%) 2 (16.7%) 3 (12.5%) 
   Renal Failure  2 (16.7%) 1 (8.3%) 3 (12.5%) 
   Cardiac Disease 0 (.0%) 1 (8.3%) 1 (4.2%) 
   Stroke    1 (8.3%) 1 (8.3%) 2 (8.3%) 
   Hypertension   1 (8.3%) 0 (.0%) 1 (4.2%) 
   Stroke & Hypertension 1 (8.3%) 0 (.0%) 1 (4.2%) 
   Other    2 (16.7%) 2 (16.7%) 4 (16.7%) 
     
Previous HT session for pain, anxiety, or stress  
   Yes   3 (25%) 5 (41.7%)    8 (33.3%) 
   No   9 (75%) 7 (58.3%) 16 (66.7%) 
     
Previous Music session for pain, anxiety, or stress  
   Yes   5 (41.7%)   1 (8.3%)   6 (25%) 
   No   7 (58.3%)  11(91.7%) 18 (75%) 
 
 
 
Analysis and Results of Data 
 
The relationship between the independent variable and the outcome variables 
(anxiety, stress, pain, pain medication usage, and the selected physiological 
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measures) was examined in this parallel-group randomized control trial (RCT). The 
data analyzed were: self-reported measures of anxiety taken from the 7-item 
Modified Generalized Anxiety Disorders scale (GAD-7), stress taken from the 10-
item Modified Perceived Stress Scale (PSS-10), pain taken from the Numeric Rating 
Scale (NRS), medical records documentation of equianalgesic opioid medication 
usage, and selected physiological data of hospital SCD adults experiencing a VOPE.  
Hypothesis 1 
Hypothesis 1 stated that the HTM group would experience lower blood 
pressure, heart rate, respiratory rate, and a higher oxygen saturation and skin 
temperature than patients receiving the ACM at completion of the interventions on 
day 1, day 2, day 3, and day 4. Table 2 reports the means and standard deviations 
of the physiological measures for pre-intervention, post-intervention, and the 
changes in scores from pre- to post-intervention for days 1, 2, 3, and 4 between the 
HTM and ACM groups. There were three mean comparisons among the 
physiological measures with statistically significant p-values: day 3 pre-intervention 
systolic blood pressure; day 2 pre – to – post intervention changes in diastolic blood 
pressure; and day 2 pre – to – post intervention changes in heart rate.  However, if 
the alpha levels were adjusted for statistical significance to 0.01 to compensate for 
multiple significance testing, none of the p-values would be statistically significant. 
Mean differences from pre – to – post intervention were greater in the HTM group for 
systolic and diastolic blood pressure on days 1 – 3, heart rate for days 1 and 3, and 
respiratory rate for days 1, 3, and 4. Oxygen saturation showed greater 
improvement, although not statistically significant for the HTM group on days 1 and 
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3, while skin temperature was increased on days 1 and 2 for the HT group, but again 
not statistically significant. Based on the findings from this pilot study, a trend was 
noted towards a reduction in the physiological parameters identified in this study that 
would tend to support hypothesis 1. A larger sample size is needed however, to 
determine if this trend would reach statistical significance.  
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Table 2  
 
Between HTM and ACM Group Comparisons of Physiological Measures at Pre and 
Post Intervention, and Pre- to Post-Intervention Change on Each Treatment Day 
 
          HTM                  ACM  
  N M SD  N M SD p1 
 
Systolic BP 
 
Day 1 Pre   12                   131.17 20.47  12 115.5 21.78 0.08 
 Post 12 125.83 22.51  12 112.75 19.63 0.14 
 Pre – Post 12 5.33 14.49  12 2.75 10.00 0.62 
Day 2 Pre 12 127.17 20.95  10 120.10 24.22 0.47 
 Post 12 120.58 18.28  10 126.00 18.15 0.50 
 Pre – Post 12 6.58 20.00  10 -5.90 14.72 0.12 
Day 3 Pre 11 129.91 24.95  9 107.56 13.62   0.03* 
 Post 11 122.91 20.83  9 107.33 11.95 0.06 
 Pre – Post 11 7.00 13.55  9 0.22 7.41 0.20 
Day 4 Pre 11 128.00 26.22  6 112.67 17.97 0.22 
 Post 11 123.91 22.98  6 108.00 15.82 0.15 
  Pre – Post 11 4.09 13.12   6 4.67 8.71 0.93 
 
Diastolic BP 
 
Day 1 Pre 12 73.33 12.43  12 68.50 15.99 0.42 
 Post 12 71.75 15.43  12 69.17 14.63 0.68 
 Pre – Post 12 1.58 9.86  12 -0.67 6.97 0.53 
Day 2 Pre 12 75.08 12.4  10 67.90 15.68 0.24 
 Post 12 66.42 10.55  10 72.30 11.09 0.22 
 Pre – Post 12 8.67 11.29  10 -4.40 9.16    0.01* 
Day 3 Pre 11 72.55 11.61  9 66.11 11.54 0.23 
 Post 11 68.18 10.13  9 62.89 11.71 0.29 
 Pre – Post 11 4.36 7.78  9 3.22 7.26 0.74 
Day 4 Pre 11 72.27 11.8  6 69.00 11.10 0.59 
 Post 11 72.45 13.91  6 66.00 10.16 0.34 
 Pre – Post 11 -0.18 7.68   6 3.00 7.62 0.43 
 
*p<.05; 1p-values based on independent sample t-test 
 
 
 
   82
 
Table 2 continued 
 
Between HTM and ACM Group Comparisons of Physiological Measures at Pre and 
Post Intervention, and Pre- to Post-Intervention Change on Each Treatment Day 
 
 
                                         HTM   ACM 
   N     N       M SD   N    M SD p1 
 
Heart Rate 
 
Day 1 Pre 12 94.25 15.73  12 83.42 11.32 0.07 
 Post 12 92.50 13.93  12 84.42 12.57 0.15 
 Pre – Post 12 1.75 7.45  12 -1.00 6.41 0.34 
Day 2 Pre 12 90.75 19.57  10 94.00 18.29 0.69 
 Post 12 89.17 18.34  10 86.70 14.33 0.73 
 Pre – Post 12 1.58 4.30  10 7.30 7.48  0.04* 
Day 3 Pre 11 91.00 16.85  9 88.67 15.07 0.75 
 Post 11 85.09 17.86  9 88.44 14.77 0.66 
 Pre – Post 11 5.91 10.38  9 0.22 4.44 0.14 
Day 4 Pre 11 83.73 17.00  6 90.33 16.78 0.45 
 Post 11 83.64 19.78  6 90.00 12.41 0.49 
 Pre – Post 11 0.09 8.25   6 0.33 8.24 0.96 
 
Respiratory Rate 
 
Day 1 Pre 12 19.67 3.06  12 17.92 3.42 0.20 
 Post 12 17.50 2.84  12 18.25 2.77 0.52 
 Pre – Post 12 2.17 2.76  12 -0.33 3.17 0.05 
Day 2 Pre 12 18.83 3.35  10 18.80 3.80 0.98 
 Post 12 17.83 2.48  10 17.40 3.66 0.75 
 Pre – Post 12 1.00 2.34  10 1.40 3.41 0.75 
Day 3 Pre 11 20.73 4.76  9 18.00 2.00 0.13 
 Post 11 18.82 4.79  9 16.67 2.45 0.24 
 Pre – Post 11 1.91 1.92  9 1.33 1.73 0.50 
Day 4 Pre 11 19.00 4.03  6 18.0 2.83 0.60 
 Post 11 17.18 4.12  6 16.67 2.73 0.79 
  Pre – Post 11 1.82 2.27   6 1.33 1.03 0.63 
 
*p<.05; 1p-values based on independent sample t-test 
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Table 2 continued 
 
Between HTM and ACM Group Comparisons of Physiological Measures at Pre and 
Post Intervention, and Pre- to Post-Intervention Change on Each Treatment Day 
 
                                                             HTM                   ACM  
    N    M SD  N    M      SD p1 
 
Oxygen Saturation 
 
Day 1 Pre 12 97.08 2.31  12 98.17 1.95 0.23 
 Post 12 97.42 3.06  12 98.17 1.80 0.47 
 Pre – Post 12 -0.33 2.39  12 0.00 2.70 0.75 
Day 2 Pre 12 97.75 2.14  10 97.70 2.16 0.96 
 Post 12 96.92 1.88  10 97.80 3.12 0.42 
 Pre – Post 12 0.83 1.70  10 -0.10 2.03 0.25 
Day 3 Pre 11 97.09 2.70  9 98.22 2.11 0.32 
 Post 11 97.55 2.84  9 97.78 2.28 0.85 
 Pre – Post 12 -0.45 3.39  9 0.44 1.60 0.25 
Day 4 Pre 11 97.84 2.01  6 97.83 2.40 1.00 
 Post 11 97.91 2.12  6 98.33 1.97 0.69 
  Pre – Post 11 -0.07     1.89       6   -0.50 0.84  0.61 
 
Skin Temperature 
 
Day 1 Pre 12 83.24 7.64  12 84.24 9.18 0.77 
 Post 12 85.74 6.92  12 84.68 8.96 0.75 
 Pre – Post 12 -2.50 6.16  12 -0.43 2.35 0.29 
Day 2 Pre 12 84.63 7.01  10 85.78 9.28 0.75 
 Post 12 87.24 8.57  10 88.13 9.75 0.82 
 Pre – Post 12 -2.61 2.81  10 -2.35 2.76 0.83 
Day 3 Pre 11 84.56 8.23  9 84.62 8.06 0.99 
 Post 11 86.76 9.18  9 87.96 8.85 0.77 
 Pre – Post 11 -2.21 2.33  9 -3.33 5.64 0.55 
Day 4 Pre 11 81.90 7.86  6 84.17 10.28 0.62 
 Post 11 83.98 9.48  6 87.77 8.60 0.43 
  Pre - Post 11 -2.08    2.51   6 -3.60      8.73 0.59 
 
1p-values based on independent-samples t-test 
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 Table 3 reports the means and standard deviations of the pre – to – post 
change scores in the physiological measures within the HTM and ACM groups for 
each day, and the mean and standard deviation of the mean pre – to – post change 
scores over the four day period between each group. Within group mean changes 
were consistently larger in the HTM group on respiratory rate. Mean changes over 
the four-day period were larger in the HTM group on all physiological measures 
except for oxygen saturation. After adjusting the level of significance for multiple 
significance tests to 0.01, none of the within group comparisons on the physiological 
measures were statistically significant. 
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Table 3 
Within HTM and ACM Group Comparisons of Daily Pre- to Post-Intervention 
Changes and Between HTM and ACM Group Comparisons of the Mean Day 1 - 4 
Pre- to Post-Intervention Changes in Physiological Measures  
 
  
 
HTM ACM 
           
 N M SD    p1  N M SD p1 p2 
           
Systolic BP           
 
          
Day 1 12.00 5.33 14.49 0.23  12.00 2.75 10.00 0.36  
Day 2 12.00 6.58 20.00 0.28  10.00 5.90 14.72 0.24  
Day 3 11.00 7.00 13.55 0.12  9.00 0.22 7.41 0.93  
Day 4 11.00 4.09 13.12 0.33  6.00 4.67 8.71 0.25  
Day 1 - Day 4 12.00 6.50 9.90     12.00 0.38 7.47   0.10 
           
Diastolic BP           
           
Day 1 12.00 1.58 9.86 0.59  12.00 -0.67 6.97 0.75  
Day 2 12.00 8.67 11.29  0.02*  10.00 -4.40 9.16 0.16  
Day 3 11.00 4.36 7.78 0.09  9.00 3.22 7.26 0.22  
Day 4 11.00 -0.20 7.68 0.94  6.00 3.00 7.62 0.38  
Day 1 - Day 4 12.00 4.29 6.70     12.00 -0.28 5.62   0.08 
           
Heart Rate           
           
Day 1 12.00 1.75 7.45 0.43  12.00 -1.00 6.41 0.60  
Day 2 12.00 1.58 4.30 0.23  10.00 7.30 7.48 0.01*  
Day 3 11.00 5.91 10.38 0.09  9.00 22.00 4.44 0.88  
Day 4 11.00 0.09 8.25 0.97  6.00 0.33 8.24 0.93  
Day 1 - Day 4 12.00 1.81 5.41     12.00 1.39 5.18 0.85 0.45 
 
**p<.05; 1p-value based on paired-samples t-test; 2 p-value based on independent-samples t-test 
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Table 3  Continued 
 
Within HTM and ACM Group Comparisons of Daily Pre- to Post-Intervention 
Changes and Between HTM and ACM Group Comparisons of the Mean Day 1 - 4 
Pre- to Post-Intervention Changes in Physiological Measures  
 
  
 
HTM   ACM 
 N M SD p1  N M SD p1 P2 
           
Respiratory Rate           
  
         
Day 1 12.00 2.17 2.76 0 .02*  12.00 -0.33 3.17 0.72  
Day 2 12.00 1.00 2.34 0 .17  10.00 1.40 3.41 0.22  
Day 3 11.00 1.91 1.92 0.01*  9.00 1.33 1.73 0.05  
Day 4 11.00 1.82 2.27 0.02*  6.00 1.33 1.03 0.03*  
Day 1 - Day 4 12.00 1.73 1.36     12.00 0.49 1.58 0.05 0.05 
           
Oxygen Saturation           
           
Day 1 12.00 -0.30 2.39 0.64  12.00 0.00 2.70 1.00  
Day 2 12.00 0.83 1.70 0.12  10.00 -0.10 2.03 0.88  
Day 3 11.00 -0.50 3.39 0.67  9.00 0.44 1.59 0.43  
Day 4 11.00 -0.10 1.89 0.90  6.00 -0.50 0.84 0.20  
Day 1 - Day 4 12.00 0.03 1.18     12.00 -0.44 2.32   0.54 
           
Skin Temperature           
           
Day 1 12.00 -2.50 6.16 0.19  12.00 -0.43 2.35 0.54  
Day 2 12.00 -2.60 2.81 0.01*  10.00 -2.40 2.76 0.03*  
Day 3 11.00 -2.20 2.33 0.01*  9.00 -3.33 5.64 0.11  
Day 4 11.00 -2.10 2.51 0.02*  6.00 -3.60 8.73 0.36  
Day 1 - Day 4 12.00 -2.45 1.96     12.00 -1.77 3.44   0.56 
 
**p<.05; 1p-value based on paired-samples t-test; 2 p-value 1p-values based on independent-samples 
t-test 
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Hypothesis 2 
 
 Hypothesis 2 stated that the HTM group would experience lower anxiety 
scores than patients receiving the ACM at completion of the interventions on day 2 
and day 4. Table 4 presents the mean and standard deviations of the anxiety scores 
on the three observation days, and the day 1 – to – day 2 changes in anxiety, and 
the day 1 – to – day 4 changes in anxiety. There were no statistically significant 
between group differences on any of the anxiety measures. The day 1 – to – day 2 
and day 1 – to – day 4 changes in anxiety although not statistically significant, were 
all larger in the ACM group, thereby not supporting hypothesis 2.  
 
Table 4 
 
Between HTM and ACM Group Comparisons of Anxiety Measured at Day 1, Day 2, 
and Day 4, and the Day 1- Day 2 and Day 1- Day 4 Changes in Anxiety 
 
  
 
 HTM  AMC 
 N M SD  N M SD P1 
Anxiety 
                                    
Pre Day 1 12 12.83 5.72  6 14.08 6.16 0.61 
Post Day 2 12 11.08 5.21  10 10.50 6.24 0.81 
Post Day 4 11 9.45 7.13  6 7.83 4.62 0.63 
Day 1 - Day 2 12 1.75 6.18  10 3.40 7.00 0.56 
Day 1 - Day 4 11 3.18       7.59   6       6.83      2.48  0.28 
 
1p-value based on independent-samples t-test 
 
 
 Table 5 presents the mean and standard deviations of the day 1 – to – day 2 
and day 1 – to – day 4 within group changes in anxiety. There was a statistically 
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significant reduction in anxiety from day 1 – to – day 4 in the ACM group, again not 
supporting hypothesis 2. 
Table 5 
 
Within HTM and ACM Group Changes for Anxiety from Day 1 to Day 2 and 
from Day 1 to Day 4  
 
 
 
HTM  ACM 
 N M SD P1  N M SD P1 
 
 
        Anxiety 
 
Total score GAD 
         
   Day 1 – Day 2  12 1.75 6.18 0.35  12 3.40 7.00  0.16 
          
   Day 1 - Day 4 11 3.18 7.59 0.19  6 6.83 2.48  0.01** 
          
 
p<.01; 1p-value based on paired-samples t-test 
 
 
Hypothesis 3 
 
Hypothesis 3 stated that the HTM group would experience lower stress scores than 
patients receiving the ACM at the completion of the interventions on day 2 and day 
4. Table 6 presents the mean and standard deviations of the stress scores on the 
three observation days, and the day 1 – to – day 2 changes in stress, and the day 1 
– to – day 4 changes in stress. There were no statistically significant between 
groups differences on any of the stress measures. The day 1 – to – day 2 changes 
in stress was larger in the AMC group, while the day 1 – to – day 4 changes in stress 
was larger in the HTM group. 
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Table 6 
 
Between HTM and ACM Group Comparisons of Stress Measured at Day 1, Day 2, 
and Day 4, and the Day 1- Day 2 and Day 1- Day 4 Changes in Stress  
 
 
 
HTM  AMC 
 N M SD  N M SD p1 
         
Stress 
         
Pre Day 1 12 25.42 8.28  12 24.33 7.63 0.74 
Post Day 2 12 20.67 5.69  10 18.80 8.73 0.55 
Post Day 4 11 17.09 9.01  6 17.00 6.81 0.98 
Day 1 - Day 2 12 4.75 6.28  10 5.40 7.26 0.82 
Day 1 - Day 4  11    8.64      9.39   6  6.33  4.97   0.59 
 
1p-value based on independent-samples t-test 
 
  
Table 7 presents the mean and standard deviations of the day 1 – to –  day 2 and 
day 1 – to – day 4 within group changes in stress. There were statistically significant 
reductions in stress from day 1 – to – day 2 and from day 1 – to – day 4 for the HTM 
group, and a day 1 – to – day 4 statistically significant reductions in stress for the 
ACM group. These results support tend to partially support hypothesis 3, since there 
was statistically significant reductions at both assessment times for the HTM group 
indicating a quicker response to the intervention than seen in the ACM group.  
 
 
 
 
 
   90
Table 7 
Within HTM and ACM Group Changes for Stress from Day 1 to Day 2 and 
from Day 1 to Day 4  
 
 
 HTM  ACM 
 N M SD p  N M SD P 
 
               
         Stress 
 
Total score PSS 
          
   Day 1 –Day 2 12 4.75 6.28 0.02*  12 5.40 7.26 0.43 
 
   Day 1 - Day 4 11 8.64 9.39 0.01*  6 6.33 4.49  0.03* 
          
 
p<.05, **p<.01, *p<.05; 1p-value based on paired-samples t-test 
 
 
 
Hypothesis 4  
 Hypothesis 4 stated that the HTM group would experience lower pain scores 
than patients receiving the ACM at the completion of the interventions on day 1, day 
2, day 3, and day 4. Table 8 reports the means and standard deviations of present 
pain for pre-intervention, post-intervention, and the changes in scores from pre- to 
post-intervention for days 1, 2, 3, and 4 between the HTM and ACM groups. There 
was one mean comparison in present pain at post day 4 that was statistically 
significant. If the alpha level was adjusted for statistical significance to 0.01 to 
compensate for multiple, significance testing, this p-value would no longer be 
statistically significant. However, the pre – to – post intervention reductions in 
present pain were greater in the HTM group at all intervention days.  
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Table 8 
 
Between HTM and ACM Group Comparisons of Present Pain at Pre and Post 
Intervention, and Pre- to Post-Intervention Change on Each Treatment Day 
 
 
                                                        HTM  ACM 
N M SD     N M  SD  p1 
 
 
 p<.05; 1p-values based on independent-samples t-test 
 
 
Table 9 reports the means and standard deviations of the pre – to – post 
change in present pain within the HTM and ACM groups for each day, and the mean 
and standard deviation of the mean pre – to – post changes in pain over the four day 
period between each group. Within group mean changes in pain were larger in the 
HTM group compared to the ACM group at each day, but not statistically significant.  
Mean changes in pain over the four-day period were larger in the HTM group 
compared to the ACM group.  After adjusting for multiple significance testing, only 
the within group comparison of pain at day 1 in the HTM group remained statistically 
significant for a reduction in pain. The between groups results did not support 
Present pain 
 
Day 1 Pre 12 6.83 1.85  12 7.83 1.59 0.17 
 Post 12 5.17 2.79  12 6.92 2.47 0.12 
 Pre - Post 12 1.67 1.50  12 0.92 1.44 0.23 
Day 2 Pre 12 6.25 1.49  10 6.90 1.91 0.38 
 Post 12 4.50 2.94  10 5.90 2.81 0.27 
 Pre - Post 12 1.75 2.34  10 1.00 1.25 0.37 
Day 3 Pre 11 5.68 1.55  9 6.78 1.79 0.16 
 Post 11 4.23 2.60  9 5.78 2.11 0.17 
 Pre - Post 11 1.45 1.81  9 1.00 2.06 0.61 
Day 4 Pre 11 5.32 2.17  6 7.17 1.84 0.10 
 Post 11 4.55 2.54  6 7.17 1.33    0.03* 
           Pre - Post 11 0.77 1.57  6 0.00 1.10 0.30 
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hypothesis 4, but again the reduction in pain scores from pre to post intervention 
within the HTM group tends to support the hypothesis that HT does reduce pain in 
the SCD patient experiencing a VOPE. 
 
Table 9 
 
Within HTM and ACM Group Comparisons of Daily Pre- to Post-Intervention 
Changes and Between HTM and ACM Group Comparisons of the Mean Day 1 - 4 
Pre- to Post-Intervention Changes in Present Pain 
 
  
 
HTM   ACM 
 N M SD p1  N M SD p1 p2 
           
Present Pain           
           
Day 1 12.00 1.67 1.50 0.00**  12.00 0.92 1.44 0.05  
Day 2 12.00 1.75 2.34 0.03*  10.00 1.00 1.25 0.03*  
Day 3 11.00 1.46 1.81 0.02*  9.00 1.00 2.06 0.18  
Day 4 11.00 0.77 1.57 0.13  6.00 0.00 1.10 1.00  
Day 1 - Day 4 12.00 1.41 1.36     12.00 0.85 1.36   0.33 
 
 
*p<.05; **p<.01, 1p-value based on paired-samples t-test; 2 p-value based on independent-samples   
t-test 
 
 
Hypothesis 5  
 Hypothesis 5 stated that the HTM group would require less pain medication 
than patients receiving the ACM at the completion of the interventions on day 1, day 
2, day 3, and day 4. Table 10 shows the results of an independent-sample t-test, 
which indicated no statistical significance in the amount of daily equianalgesic opioid 
medication used between the HTM and ACM groups. The overall equianalgesic 
opioids medication usage for the HTM group was consistently higher from pre 
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intervention throughout the four days studied and thereby hypothesis 5 was not 
supported by these results. This trend for higher medication in the HTM group was 
consistent with the fact that the other physiological parameters (i.e. B/P, HR) were 
higher as well, and may be due to the higher acuity of this group (more co-
morbidities). In order to determine the rationale behind this however, a larger sample 
size would be needed. 
 
 
 
  1p-value based on independent-samples t-test 
 
Summary 
 This chapter provides an analysis of the sample and the statistical tests used 
to analyze the two intervention groups, HTM and ACM, to determine the 
effectiveness of each in reducing anxiety, stress and/or pain, and the overall 
findings. Although there was no statistical significance found between HTM and 
ACM groups, probably due to the small sample size, the analysis of the data did 
show some important trends that will be discussed in Chapter 5.  
Table 10 
Between HTM and ACM Group Comparisons of Daily Equianalgesic Opioid 
Medication Usage 
 
 
HTM ACM 
 N M SD  
 
N M SD P1 
 
Day 1 12 164.90 139.05  12 98.23 51.27 0.13 
Day 2 12 149.70 124.59  10 124.98 44.73 0.56 
Day 3 11 191.50 177.09  9 116.66 77.29 0.26 
Day 4 11 128.90 79.12  6 96.97 53.22 0.39 
Day 1 – Day 4 11 601.89 499.34  6 338.35 198.42 0.10 
          
  
CHAPTER V: DISCUSSION, CONCLUSIONS, RELEVANCE, AND    
  RECOMMENDATIONS 
 
Discussion 
 
 The analysis of the data collected during this study did not reveal statistically 
significant results between the HTM group and the ACM group, possibly due to the 
small sample size. However, the data did show some interesting trends within the 
groups that will be discussed in this chapter along with the biases, limitations of the 
study, barriers to real-world implementation, generalizability of the findings, and 
relevance to nursing.  
Conclusions 
 Theoretical model. 
Neuman’s System Model, the theoretical model used to frame this study 
(Neuman & Fawcett, 2002), encompasses the idea of a dynamic interaction that occurs 
between people and the environment and the mechanisms that are used to protect 
against stressors (i.e. pain, anxiety, and stress). It was noted that those participants 
who experienced pain reduction at the first intervention time tended to sustain that 
reduction over the entire treatment period. This sustained response to the interventions 
seen with the HTM group is consistent with the secondary prevention described by 
Neuman that attempts to strengthen the lines of resistance to help the participant 
defend against the physiological stressors, as well as anxiety and stress in order to 
restore his/her balance in the energy system reflected in the trending of the 
physiological measures in a positive direction, partially supporting the study hypotheses 
1-4.  
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 Hypotheses. 
 Hypothesis 1 stated that the HTM group would experience lower blood pressure, 
heart rate, respiratory rate, and a higher oxygen saturation and skin temperature than 
patients receiving the ACM at completion of the interventions on day 1, day 2, day 3, 
and day 4. Participants in both groups experienced reductions in systolic blood 
pressure, diastolic blood pressure, and heart rate, as well as an increase in skin 
temperature, but these within group changes were greater in the HTM group.  
 The trend previously described in the data analysis implies an effect on some of 
the physiological measures in both the intervention and control group. This effect is 
what would be expected from the biological changes induced by relaxation, which has 
been previously demonstrated in music therapy studies by Updike (1990), Smolen, 
Topp, and Singer (2002), Sendelbach et al. (2006). In addition to the physiological 
measures, the pain and its resultant effects on the sympathetic nervous system’s 
release of epinephrine and norepinephrine, would cause an increase in heart rate, blood 
pressure and a reduction in skin temperature (Kleinknecht, 2002; McCrae & Lumley, 
1998). However, relaxation produces a decrease in the sympathetic nervous system’s 
response, thereby reducing these physiological measures as seen in this study. This 
finding of reduced physiological measures is consistent with those found by Maville, 
Bowen, and Benham (2008) in their study using HT on healthy adults. These findings 
reflect the possible influence of the HT intervention, but the effect of the music therapy 
cannot be ruled out, therefore further study with HT is needed.  
Hypotheses 2 and 3 stated that the HTM group would experience lower anxiety 
and stress scores than patients receiving the ACM at completion of the sessions on day 
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2 and day 4. When making between-groups comparisons for anxiety and stress, there 
were no statistically significant results to report. For anxiety, the within-group 
comparisons showed a larger improvement only for the ACM group for both time 
frames. However, for stress, the between-groups comparison showed a larger reduction 
initially for the ACM group, but this was not maintained at day 4, while the HTM group 
showed a larger reduction in stress at day 4. The within group improvement changes in 
stress were found to be statistically significant for the HTM group after day 2 and day 4, 
while the ACM group showed statistically significant improvement after day 4.  
The finding of a statistically significant reduction in the stress for the HTM group 
seen at day 2 and again at day 4 is consistent with the findings of other studies (Heidt, 
1981; Meehan, 1993; Wardell & Engebretson, 2001; Wardell & Weymouth, 2004; 
Wilkinson et al., 2002) in HT, which examined selected physiological data related to 
anxiety and/or stress, partially supporting hypothesis 3. The ACM group also showed 
some reduction in stress over time, which was possibly related to the interaction of the 
addition of music to the environment, but the HTM group showed a greater reaction to 
the intervention, pointing to an increased effect that resulted from adding HT to the 
intervention similar to the results seen by Dowd et al.(2007) in their study on stress with 
college students. 
Hypothesis 4 stated that the HTM group would experience lower pain scores 
than patients receiving the ACM at the completion of the sessions on day 1, day 2, day 
3, and day 4. When making between-groups comparisons, the only statistically 
significant result was the post-intervention score on day 4 for the ACM group. The pre to 
post intervention reductions in present pain were greater in the HTM group than the 
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ACM group across all 4 days. The only statistically significant findings for present pain 
reduction however, were found in the HTM group at post intervention on day 1, which 
was consistent with Weymouth and Sandburg-Lewis’s (2000) findings in their study with 
chronic neuropathic pain. Again, the fact that the HTM group had a larger mean change 
in pain scores over the four-day period as compared to the ACM group tends to partially 
support Hypothesis 4. 
Another interesting trend noted was that 50% of the HTM participants (n=6) 
reported a pain reduction of 2 or more points (SD + 1.03) at the first intervention, but 
only 25% of the ACM participants (n=3) reported a pain reduction of 2 or more points 
(SD + 1.64). Additionally, for both groups, those with pain reductions of 2 or more points 
at the first session had a larger mean pain reduction across all sessions than those 
participants whose pain reduction at the first session was less than 2 points. This finding 
is consistent with the results Post-White et al. (2003) found with the effects of HT on 
immediate pain reduction in the chemotherapy patients in their study. For the HTM 
group, the larger results (50% greater reduction) could be due to the outcome obtained 
by the HT intervention or maybe the anticipated effect of this new intervention by the 
study participant. More studies will need to be conducted in this area.   
Attempts to control for the therapeutic presence versus the physical presence 
effect were addressed during the design of the study by having the RAs in the room for 
the ACM interventions, but more studies to address this aspect of the effect need to be 
conducted. Lastly, this current study will add to the body of knowledge that can be used 
in conducting systematic reviews of quantitative studies involving HT to establish 
credibility of this type of touch therapy for pain relief.  
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Hypothesis 5 stated that the HTM group would require less pain medication than 
patients receiving the ACM at the completion of the interventions on day 1, day 2, day 3, 
and day 4. This hypothesis was not supported by the findings; however there was a 
trend for reduction in overall pain usage among both groups.  
Although the study findings were not statistically significant between the two 
groups, the changes noted within the HTM group do tend to partially support the original 
hypotheses, but a larger sample size is necessary to confirm this.  
Study Validity and Threats 
 Internal validity. 
Control for issues related to internal validity was addressed for this study by the 
research design that was developed, which was a parallel-group RCT using two 
interventional groups. A permuted block randomization scheme was used to control for 
selection bias, while ensuring an equal number of participants in each group. The use of 
specific selection criteria to limit preexisting differences in the intervention groups 
helped to reduce selection bias. The issue of maturation was addressed by the design 
of the study because all participants were enrolled and the first intervention given by 
day two of admission to the facility, and subsequent interventions were provided over 
the next four days for all participants. Attrition of participants was an issue however, due 
to the participants being discharged from the facility prior to completion of the study, 
except for one participant in the HTM group who chose to drop out after the first 
intervention. This attrition rate was greater for the ACM group; this may have been due 
to the fact that the ACM group had less co-morbidities and were discharged sooner than 
the HTM group. 
   99
By using already validated measurement instruments, the study design provided 
credibility for the information collected, however the mere collecting of data can impact 
the results obtained. This needs to be considered when analyzing the results of self-
reported measures. 
 Construct validity. 
 In an effort to guarantee the accuracy of the findings in the study, the consistency 
of the sessions, both the HTM and the ACM, by the RAs were scripted to ensure that 
the interaction between the patients and the RAs was the same. To control for variation 
in the administration of the HT intervention, inter-rater reliability was conducted for four 
of the sessions for each of the HT RAs to ensure that the HT protocols were followed. 
This was done to establish that the HT intervention used in this study represented the 
general practice of HT. 
Looking at the instruments chosen for this study, the construct validity for the 
GAD-7 has been previously established as an efficient tool for screening for anxiety in 
the clinical practice setting, however for this study the GAD-7 was modified to address 
the shorter study time. This modification in the GAD-7 may account for the lack of 
statistical significance in the between groups analysis in this study, since it has not been 
studied for this time frame. The PSS-10 instrument that was used to assess for changes 
in stress levels however, has been studied using this shorter time frame, and the test-
retest reliability did show substantial correlations to PSS that was tested for a longer 
time frame. The last instrument used was the NRS, which has been shown to be highly 
correlated with other pain assessment tools. The use of valid instruments to measure 
our outcome variables adds to the construct validity of this study. Having established 
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that the HT intervention was representative of the general practice of HT and that the 
instruments used to measure the outcome variables (i.e. anxiety, stress, and pain) were 
reliable, added to the construct validity of the study design. 
The study design also included the use of the participant’s medical record in 
order to validate the reduction in pain by assessing the amount of pain medication used 
and comparing it to the self-reported pain scores. This was done to address the 
possibility of the Hawthorne effect. In reviewing the actual pain medication usage for the 
HTM group, the overall amount of pain medication did decrease over the study time, as 
did the pain scores, however the HTM group did use more pain medication than the 
ACM group. This again may have been related to the larger percentage of the HTM 
group’s co-morbidities, however a definitive link between the actual medication usage 
and the decrease in pain scores cannot be made, since only the overall usage was 
studied.  
Another threat to the construct validity is the novelty effect, since the HT 
intervention is a new complementary therapy technique that has not historically been 
used in the SCD patient population. Those participants receiving HTM could have been 
either enthusiastic or skeptical about it. The one participant who dropped out of the 
study revealed that she was indeed skeptical about the effect of the HT intervention and 
did not want to continue in the study.  
Another potential threat to the construct validity would be the bias of the RC who 
is a CHTP and has a vested interest in obtaining a positive outcome from this study. An 
attempt to alleviate this possible threat to the construct validity was addressed by 
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having RAs, who were not providing the intervention, collect the data from the study 
participants.  
 External validity. 
In addressing the generalizability of this current study to the overall healthcare 
system, the fact that HT is a non-invasive nursing intervention that can be administered 
to any patient at the bedside makes it easy to implement in any setting. The RA 
administering the HTM intervention in this study was a more experienced practitioner 
(CHTP and HTP-A), which would decrease the generalizability of this study, however 
previous studies examining the expertise of the HT provider on pain noted that the less 
experienced providers had less effect, but regardless, there was still an overall positive 
effect noted on pain reduction (So, Jiang, & Qin, 2008).   
Another potential problem with generalizing these HT research findings to all 
healthcare facilities is the novelty of this type of complementary therapy and its 
acceptance in mainstream healthcare. Although complementary therapies are beginning 
to find their place in healthcare, the acute care facility is slow to accept this new 
treatment option and represents a possible limitation for implementing this study’s 
findings. 
 Limitations. 
There were several limitations noted during the study related to the performance 
of the interventions. One such limitation was in the timing of the interventions. The study 
design was established such that the interventions would be given during the “quiet 
time” at the facility, but due to the day-to-day operations of the units (procedures, labs, 
x-rays, etc.) as well as timing of pain medications and blood transfusions, this was not 
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always possible. Whether the results of the participants’ self-reported scores were 
influenced by the time of day would need to be examined. The timing of pain medication 
administration and the actual treatment was addressed in the study design by allowing 
at least one hour after medication administration prior to the intervention or control 
sessions. This however, did not address whether it had been two, three, or more hours 
since the participant had had pain medication, which did occur and could have impacted 
the self-reported scores of the participants.   
Another limitation was related to the number of interruptions experienced during 
the intervention process. The study design attempted to address this by notifying the 
participant’s nurse prior to the start of the intervention to ensure that there would not be 
a need for any nursing care procedures during the intervention time and by placing 
signs on the doors to alert staff and visitors of the intervention that was in progress. 
Unfortunately, this still did not prevent interruptions during some interventions. 
Lack of knowledge about the HT therapy concept presented another limitation for 
the study due to lack of physician understanding of the practice. The PI addressed this 
by providing an hour lecture to a group of primary admitting physicians on the practice 
of Healing Touch and its expected benefits. 
Lastly, the timely notification of potential study participants was a limitation that 
resulted in not being able to enroll possible study participants, therefore limiting the 
sample size. This was addressed initially in the study design by letters being sent to the 
entire medical staff at the facility. However, due to lack of acknowledgement and 
support, the PI then met individually with the primary admitting physicians for SCD 
patients, as well as the Medical Director for the facility, who then facilitated the 
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computer notification of admissions. This proved to enhance the notification of all SCD 
patient admissions, enabling timely screening for possible enrollment and primary 
physician approval. Barriers to access of the patient population should be addressed in 
the initial study design to ensure resolution of this problem and adequate sample size in 
future studies. 
Relevance to Nursing 
Sickle cell disease patients experiencing a VOPE require numerous nursing 
interventions (i.e. pain medication administration, blood transfusions, etc.), but this 
patient population also requires a lot of social interaction, which often times is avoided 
by healthcare providers. Healing Touch, a heart centered, caring practice, allows the 
nurse to provide that portion of nursing which is unique to the profession of nursing, that 
of caring.  In today’s highly technologically driven healthcare system, the practice of HT 
that provides a gentle, non-invasive intervention, restoring balance to the patients’ 
energy system, and assisting them in their healing process, whether physiologically, 
psychologically, or socially, and could provide the nurse as well as the patient with a 
sense of well-being, is very much needed today. 
With today’s healthcare costs rising, finding an intervention that the bedside 
nurse can administer could help to address these costs. If statistical significance can be 
established showing that HT, a non-invasive therapy, can reduce the overall use of 
pharmaceuticals and their side effects, thereby reducing the length of stay in the 
hospital, then this could have clinical significance for the bedside nurse who could offer 
this beneficial treatment option to the SCD patient. In the SCD patient who experiences 
frequent admissions to the hospital, the nurse could also possibly impact the SCD 
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patient’s care by developing clinical practice guidelines based on solid evidence based 
research. Lastly, educating the SCD patient in HT techniques that could help to promote 
wellness by reducing the stressors of anxiety and stress, could also have clinical 
significance for the SCD patient population. 
Recommendations for Further Research 
Even though this study had a small sample size, the positive results that were 
obtained within the HTM group indicates the evidence for further research to determine 
whether there would be statistically significant results seen across a larger sample size 
and in similar patient populations, with similar issues of pain, anxiety, and stress.  
Further research is needed looking at not only the physiological variables, but 
also at biomarkers such as IgA to determine the impact of HT on the immune system in 
order to provide a more scientific basis for HT. There also needs to be more research 
into the use of HT in the psychosocial or behavioral aspects of this type of therapy, 
since there was statistically significant reduction noted in the stress levels of this SCD 
group. 
Additional research should be conducted into the standardization of HT 
techniques, the optimal time for treatments, as well as the number and frequency of 
these interventions, in order to determine the best practice. Further research should 
also be conducted into the effect of the training of the HT practitioner to determine at 
what minimum level of training would be required for the bedside nurse.  
Summary 
 Sickle cell disease is a devastating illness and is a major healthcare problem 
affecting approximately one out of every 375 African-Americans in the United States 
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(Edwards et al., 2005), as well as other populations from the Caribbean, Southern 
Europe, the Mediterranean area, the Middle East, and India (NAHAT, 1991). This 
worldwide health problem affects both men and women of all ages across their entire 
lifespan. The major complication of SCD is the occlusion of the vascular beds and the 
resultant ischemia, which causes the VOPE (Metha, Afenyi-Annan, Byrns, & Lottenberg, 
2006; Steinberg & Brugnara, 2003). The optimal management of SCD requires a 
multidisciplinary team approach due to the multidimensional aspect of the reoccurring 
SCD pain, related to the biological, psychological, behavioral, social, and cultural 
components of the disease (Yale, Nagib, & Guthrie, 2000).  
 This pilot parallel-group RCT was conducted to examine a complementary 
therapy approach using HTM to manage a VOPE. Its purpose was to determine the 
effectiveness of this non-invasive nursing intervention on anxiety, stress, pain, pain 
medication usage, and physiological measures (i.e. blood pressure, heart rate, 
respirations, oxygen saturation, and skin temperature) of hospitalized SCD adults 
experiencing a VOPE. The effect of HTM on the outcome variables was measured, 
while controlling for the variables music and presence. The results, although not 
statistically significant across the two groups, did suggest a possible positive effect that 
should continue to be studied.  
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Appendix A – Demographic Information     
 
 
  Study # __________       Date: __________        Time: __________ 
 
 
1. Age: ____ 
 
 
2. Sex: ____ Male ____ Female   
 
 
3. Ethnicity: ____ African–American Black   
 ____ Mediterranean/Middle East  
 ____ Caribbean  
 ____ Asian    
 ____ Indian (India) 
 ____ Other ____________________________________ 
 
 
4. Type of SCD:  Hemoglobin SS   Hemoglobin SC  
   Hemoglobin SD,    Sickle-thalassemia 
 
 
5. Co-morbidities:  ____ None    ____ Cardiac Disease  
  ____ Smoker   ____ Diabetes   
  ____ Renal Failure   ____ Hypertension 
  ____ Stroke    
  ____ Other: ______________________________ 
 
 
6. Number of previous hospitalizations for SCD:   ____ 0 ____ 4 
  ____ 1 ____ 5  
  ____ 2 ____ 6 
    ____ 3 ____ 7 or > 
 
7. Current pain management techniques:  
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________ 
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 8.  When did you last take something for pain and what was it?   
 
  Drug Name: ______________________________________________ 
  Dosage: _________________________________________________ 
  Time:____________________________________________________ 
 
  Drug Name: ______________________________________________ 
  Dosage: _________________________________________________ 
  Time:____________________________________________________ 
 
 
9.  Have you ever had a HT session?            ____ Yes    ___No 
 
10.  Have you ever had a Guided Relaxation session?    ____ Yes   ___ No 
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   Appendix B – Numeric (Pain Intensity) Rating Scale (NRS) 
 
    Study ID # ________   Date: ________    Session # _______   Time: _______ 
     
 
 
 
                  
      
                  0        1        2        3        4        5        6         7        8        9        10                                           
             No Pain                                Worst    
                 Possible Pain 
 
 
 
1. Please rate your present pain on the above scale of 0-10,  
       with 0 being no pain and 10 being the worst possible pain.   Score: _____ 
 
 
2. Please rate your worst pain in the past 24 hours on the  
 above scale of 0-10, with 0 being no pain and 10 being 
 the worst possible pain.        Score: _____ 
 
 
3. Please rate your least pain in the past 24 hours on the  
 above scale of 0-10, with 0 being no pain and 10 being  
 the worst possible pain.        Score: _____ 
 
 
4. Please rate your average pain in the past 24 hours on the  
 above scale of 0-10, with 0 being no pain and 10 being  
 the worst possible pain.        Score: _____ 
 
 
 
Physiological data: 
 
  Heart rate: _______     Respiratory rate:  _______ Blood pressure:  ________ 
 
  O2 Sats: ________       Skin Temp:  _______0 F 
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Appendix C – Modified Generalized Anxiety Disorder Scale (GAD-7)  
 
Study # _______ Date ________ Time ________ Session # ________ 
 
 
□  Pre-Assessment   □   Post-Assessment  
 
 
 
GAD - 7 
 
Over the last 2 days, how often have you been             Not      Several     More than    Nearly all 
 bothered by the following problems?                           at all      times a      half the         the time    
                                                                                                      day        time each        every  
                                                                                                                        day               day                       
 
 
1. Feeling nervous, anxious or on edge                 0                1                2                3      
 
 
2. Not being able to stop or control worrying          0                1                2                3 
 
 
3. Worrying too much about different things           0                1                2                3 
 
 
4. Trouble relaxing                                                  0                1                2                3 
 
 
5. Being so restless that it is hard to sit still            0                1                2                3 
  
 
6. Becoming easily annoyed or irritable                  0                1                2                3 
   
 
7. Feeling afraid as if something awful                    0               1                2                3          
might happen     
 
 
 
       Total Score  =  _______       Add       _____  +   _____  +   _____  +  _____  
                     Columns 
 
 
 
 
 
*Modified from Generalized Anxiety Disorders Scale (GAD) 7 developed by Dr. Robert Spitzer 
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Appendix D: Modified Perceived Stress Scale   
 
Study # _______ Date ________ Time ________ Session # ________ 
 
  Pre-Assessment    Post-Assessment    
 
 
The questions in this scale ask you about your feelings and thoughts. In each case, you will be 
asked to indicate by circling how often you felt or thought a certain way. 
 
 
0 = Never      1 = Almost Never      2 = Sometimes      3 = Fairly Often      4 = Very Often 
 
 
1. In the last 2 days, how often have you been upset because of something  
    that happened unexpectedly? ........................................................................  0 1 2 3 4 
 
2. In the last 2 days, how often have you felt that you were unable to control 
    the important things in your life?....................................................................   0 1 2 3 4 
 
3. In the last 2 days, how often have you felt nervous and “stressed”? ............   0 1 2 3 4 
 
4. In the last 2 days, how often have you felt confident about your ability 
    to handle your personal problems? ...............................................................   0 1 2 3 4 
 
5. In the last 2 days, how often have you felt that things were going your               
    way?..............................................................................................................    0 1 2 3 4 
 
6. In the last 2 days, how often have you found that you could not cope with  
    all the things that you had to do? ................................................................    0 1 2 3 4 
 
7. In the last 2 days, how often have you been able to control irritations in your  
    life?.................................................................................................................   0 1 2 3 4 
 
8. In the last 2 days, how often have you felt that you were on top of things?...  0 1 2 3 4 
 
9. In the last 2 days, how often have you been angered because of things  
          that were outside of your control? ................................................................   0 1 2 3 4 
 
 10. In the last 2 days, how often have you felt difficulties were piling up so  
          high that you could not overcome them?...................................................       0 1 2 3 4 
 
 
 
 
 
 
* Modified from The Perceived Stress Scale (PSS) developed by Sheldon Cohen 
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Appendix E: Healing Touch Protocols 
Once the baseline data has been collected, a sign is placed on the participant’s 
room door advising that a Healing Touch treatment is in session and Do Not Disturb 
until (_____) time. Next the participants are asked to lie on their back and if necessary, 
pillows are placed under the knees for comfort. Any other additional comfort measures 
that the participant requires are addressed prior to starting the HT treatment. The 
curtains are closed and any distractions (i.e. TV, phones, etc.) are turned off.  
The HT-RA explains that the treatment will take approximately 25-30 minutes. The 
HT-RA asks the participants if there is any area that is currently bothering them or if 
there is anything that they would like the HT-RA to work on. The participant is told that 
the HT-RA will work on those areas where she feels there is blockage or congestion, 
but that all the work will be done off the body except for touching the feet. The HT-RAs 
then reminds the participants that this is a research study and that they will not be 
talking to them during the treatment, but at any time that they need to tell them anything, 
to please speak up.    
Healing Touch Sequence/Protocols 
1. Intake: Discuss with participants the purpose of the Healing Touch treatment and 
obtain permission.   
2. Practitioner preparation: Ground and center self. Attune to participants by holding 
both feet. 
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3. Pre-treatment assessment:  Perform a Hand Scan and pendulum to assess the 
openness of the chakras and the energy fields, looking for differences in the energy flow 
and document on the HT Assessment Form.  
4. Discuss with participants any problems noted and if there are any areas that the 
participants would like the HT-RA to work on. 
5. Perform the following HT intervention: Chakra Connection 
 
i. Participants are positioned lying on their back with pillow under knees.  
ii. HT-RAs stands on the right side of the participants and place their hands 
 gently over the specific energy centers known as chakras.   
iii. Each position is held in place for one minute. 
iv. Move the hands one at a time, maintaining the connection.  
v. The pattern follows the sequence below:  
 
a. Right ankle and right knee 
b. Right knee and right hip 
c. Left ankle and left knee 
d. Left knee and left hip 
e. Both hips 
f. Root and sacral chakras 
g. Sacral and solar plexus chakras 
h. Solar plexus and spleen 
i. Solar plexus and heart chakra 
j. Heart chakra and high heart 
k. Right wrist and right elbow 
l. Right elbow and right shoulder 
m. Left wrist and left elbow  
n. Left elbow and left shoulder 
o. Both shoulders   
p. High heart and throat chakra 
q. Throat chakra and brow chakra 
r. Brow chakra and crown chakra 
s. Crown chakra and transpersonal point. 
 
6. Based on assessment and intake of patient, perform the following: Hands in Motion, 
and Hands Still over the participant where needed for 5 minutes.  
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7. If the participant’s pain score was 5 or >, perform the Ultrasound technique for 2 
minutes followed by 3 minutes of a Pain Drain in the area where the pain is focused. 
8. Perform a post-treatment assessment using a Hand Scan and pendulum to 
assess the openness of the chakras and the energy fields. Document the post-
treatment assessment data.  
9. End the session by grounding and releasing the patient by holding both feet and 
talking to them to bring them back into awareness of the room. Ask the participant to 
describe anything they may have experienced and document on HT Assessment  Sheet.  
10.  Notify DC-RA to administer the pre-treatment surveys again to the participants 
approximately 10 minutes after the HT treatment. 
11.  Thank participants and schedule next session.  
Magnetic Passes 
Hands in Motion is a technique used to clear congestion from the field and Hands Still is 
used to re-establish flow and balance. Magnetic Passes help to relieve pain, promote 
relaxation, decrease anxiety, tension, and stress and promote a sense of well-being. 
Procedure for Hands in Motion: 
1. Place both hands one to six inches above the physical body in the energy field. 
2. Hold hands open with palms facing the body, softly brushing down and away with 
either one hand following the other or both moving in a parallel motion downward 
and away from the body. 
3. Start with the upper body and move to the lower body. 
4. Hands should move completely off the body far enough for pain and congestion 
to dissipate.   
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5. This technique is done over entire body or over a specific site of injury or pain. 
Procedure for Hands Still: 
1. Rest the hands on or off the body in the area of concern.  
2. Hands can be in front or back, next to each other or around a joint.  
3. Hold in place for one minute, if energy flow not initiated, hold for one more 
minute. 
4. Energy flow or release of energy should be noted such as either a fullness or 
change in temperature indicating the energy has shifted, resulting in balance or 
energy flow.   
Ultrasound 
 Ultrasound uses light that is focused or channeled. By using the thumb, first    and 
second fingers, which are held together to focus the light, the HT-RA energy penetrates 
the areas needing attention with the energy. Using this hand position the energy is 
circulated through the area using a constant circular motion.   
Procedure: 
1. Hold the thumb, first and second fingers together, directing the energy from the 
palm down the fingers. 
2. Imagine a beam of light coming from the fingers and thumb that is   directed into 
the participant’s body. 
3. Move the whole hand in any direction desired with the fingers pointed toward the 
area. Keep moving the hand continuously while doing ultrasound. 
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Pain Drain 
Pain Drain is used to help remove any physical or emotional pain or congestion in the 
field. 
Procedure:  
1. Place the left hand on or over the area that hurts or feels congested.   Hold the 
right hand downward and away from the body. This siphons the energy from the 
participant’s body and out of the HT-RA’s right hand.  Hold the position until the 
movement or sensation of pulling stops, or the participant’s feedback indicates 
relief. 
2. Reverse the hands placing the right hand on or over the participant’s area and 
hold the left hand palm upward. Allow healing energy from the Universal Energy 
Field to flow in, allowing the void created by the drain to fill with light.  
 
 
 
 
 
 
 
 
 
* The above Healing Touch techniques were based on Hover-Kramer, D. (2002). 
Healing Touch: A guidebook for practitioners (2nd ed.). Albany, NY: Delmar 
Thomson Learning.    
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Appendix F:  Healing Touch Inter-rater Form  
 
Healing Touch RA’s name:  ___________________________________________ Date: ___________ 
 
Date:      
1. Intake: Discuss with patient the purpose of the HealingTouch treatment and     
 Obtain permission.   
     
2.  HT research assistant’s preparation: Ground and center self. Attune to patient.      
3.  Pre-treatment assessment:  Perform a Hand Scan and pendulum to assess the 
openness of the chakras and the energy fields, looking for differences in the 
energy flow. Document the findings on the HT work sheet. 
     
4.  Discuss with patient any problems noted and if there are any areas that the 
patient would like the HT research assistant to work on. 
     
5.  Perform the following HT intervention: Chakra Connection      
i.  Patient is positioned lying on their back with pillow under knees.       
ii. HT research assistant stands on the right side of the patient and places his/her  
    hands gently over the following areas.  
     
iii. Each position is held in place for one minute.      
iv. Move the hands one at a time, maintaining the connection.       
iv. The pattern is as follows:       
a.  Right ankle and right knee      
b.  Right knee and right hip      
c.  Left ankle and left knee      
d.  Left knee and left hip      
e.  Both hips      
f.   Root and sacral chakras      
g.  Sacral and solar plexus chakras      
h.  Solar plexus and spleen      
i.   Solar plexus and heart chakra      
j.   Heart chakra and high heart      
k.  Right wrist and right elbow      
l.   Right elbow and right shoulder      
m. Left wrist and left elbow       
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n.  Left elbow and left shoulder      
o.  Both shoulders        
p.  High heart and throat chakra      
q.  Throat chakra and brow chakra      
r.   Brow chakra and crown chakra      
s.  Crown chakra and transpersonal point.      
6. Based on assessment and intake of patient, perform the following: Hands in 
Motion, and Hands Still over the participant where needed for 5 minutes. (Write 
either HM for Hands in Motion or HS for Hands Still). 
     
7. If the patient’s pain score was 5 or >, perform the Ultrasound technique for 2 
minutes followed by 3 minutes of a Pain Drain in the area where the pain is 
focused. (If a Pain Drain done, place a “y” for yes “n” for no). 
     
8. Perform a post-treatment assessment using a Hand Scan and pendulum to 
assess the openness of the chakras and the energy fields. Document the post-
treatment assessment data.  
     
9. End the session by grounding and releasing the patient by holding both feet and 
talking to them to bring them back into awareness of the room.   
     
 10. Thank the patient and schedule next session.      
 
 
Comments: 
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________ 
 
 
__________________________________    ___________________ 
Inter-rater signature       Date                 
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Appendix G: Script for Music Research Assistants 
 
 
Hello, my name is __________________________.  I am here to give you your Music 
Therapy treatment.  Is this a good time for you?   
 
If they say no, ask them when would be a good time and let them know you will be back 
at that time. Thank them, and then ask is there something that you can do for them 
before you go. 
  
If they say yes, then ask if it is OK to turn off the TV, phones, etc. and put the sign on 
the door that says Music Therapy in Progress Do not Disturb. Explain to them that you 
will be using an IPOD with head phones to assist them with the music session. 
 
Once you have placed the sign on the door, make the patient comfortable assist them 
with the headphones and adjust the volume so they can hear it. 
 
Pull up a chair up next to the bed for you to sit in. Tell the patient that you are going to 
be sitting here with them during the session, but will not be talking to them. Tell the 
patient if they have any questions or need anything during the session to please let you 
know. When the Music session is over, you will allow them a few minutes to enjoy the 
relaxation before speaking to them. 
 
Ask one final time if they are comfortable and tell them that you are going to start the 
session now.   
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Once the session is over, ask them if there is anything they need and thank them for 
allowing you to provide them with this Music Therapy session and that you look forward 
to seeing them again. Also tell them that another person will be in shortly to assist them 
in completing the questionnaires about how they are feeling now and take their vital 
signs.  
 
End by telling them that you hope they have a nice day. 
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Appendix H: IRB Approval Letter 
 
 
 
